https://www.pharmaceutical-business-review.com/news/galena-biopharma-gets-notice-of-allowance-of-us-patent-for-neuvax-020714-4308202/ 2014-07-02T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/curevac-sanofi-pasteur-ink-license-deal-for-mrna-based-prophylactic-vaccine-020714-4308550/ 2014-07-02T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/nutrafuels-plans-to-introduce-tapout-xt-extreme-energy-oral-spray-020714-4308761/ 2014-07-02T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/quintiles-acquires-encore-health-resources-020714-4308769/ 2014-07-02T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/ani-pharma-acquires-lithobid-tablets-from-noven-therapeutics-020714-4308841/ 2014-07-02T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/ipsen-files-marketing-authorization-applications-in-us-europe-for-somatuline-020714-4308855/ 2014-07-02T23:01:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-files-marketing-applications-for-copd-combination-drug-in-europe-030714-4309028/ 2014-07-02T23:47:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-receives-kosher-certification-for-elelyso-to-treat-type-1-gaucher-disease-030714-4309427/ 2014-07-03T04:24:00+00:00 https://www.pharmaceutical-business-review.com/news/biolight-announces-issuance-of-us-patent-for-the-long-term-controlled-release-drug-delivery-insert-platform-030714-4309453/ 2014-07-03T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/upsher-smith-launches-vogelxo-gel-in-three-convenient-configurations-030414-4309486/ 2014-07-03T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/jazz-pharma-to-acquire-rights-to-defibrotide-from-sigma-tau-030714-4309509/ 2014-07-03T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/collegium-gets-us-patent-covering-oxycodone-deterx-030714-4309528/ 2014-07-03T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/cmc-biologics-portola-pharma-partner-to-develop-andexanet-alfa-030714-4309668/ 2014-07-03T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/bind-amgen-end-cancer-drug-collaboration-030714-4309734/ 2014-07-03T06:26:00+00:00 https://www.pharmaceutical-business-review.com/news/oncomed-secures-broad-fzd-fc-composition-of-matter-and-use-patent-in-us-030714-4309808/ 2014-07-03T06:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-tentative-approval-for-eagles-nda-of-bendamustine-hydrochloride-injection-030714-4309837/ 2014-07-03T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-agrees-to-buy-seragon-pharmaceuticals-030714-4309881/ 2014-07-03T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/tweed-collaborates-with-leading-academics-for-research-040714-4310403/ 2014-07-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bioalliances-lymphoma-drug-beleodaq-gets-accelerated-approval-from-fda-040714-4310117/ 2014-07-03T23:31:00+00:00 https://www.pharmaceutical-business-review.com/news/medicure-purchases-minority-interest-in-apicore-040714-4310387/ 2014-07-04T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/advanced-cell-technology-announces-30-million-equity-facility-with-lincoln-park-capital-040714-4310514/ 2014-07-04T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/natural-alternatives-international-announces-dismissal-of-all-product-liability-suits-involving-carnosyn-beta-alanine-040714-4310524/ 2014-07-04T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-files-citizen-petition-for-approval-of-generic-copaxone-040714-4310531/ 2014-07-04T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/detained-investigator-says-mass-bribery-at-gsk-china-credible-040714-4310890/ 2014-07-04T06:25:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-dermira-to-develop-and-commercialize-cimzia-in-dermatology-040714-4310942/ 2014-07-04T06:32:00+00:00 https://www.pharmaceutical-business-review.com/news/santen-closes-asset-purchase-agreement-with-merck-for-ophthalmology-assets-040714-4310965/ 2014-07-04T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-grants-marketing-approval-for-gsk-and-genmabs-arzerra-4311023/ 2014-07-04T07:31:00+00:00 https://www.pharmaceutical-business-review.com/news/bayers-nexavar-gets-health-canada-approval-for-differentiated-thyroid-cancer-070714-4312746/ 2014-07-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/celladon-announces-new-clinical-development-initiatives-for-mydicar-070714-4312760/ 2014-07-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/roches-lung-cancer-drug-alectinib-gets-approval-in-japan-070414-4311194/ 2014-07-06T23:49:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-buys-two-generic-products-from-actavis-070714-4311561/ 2014-07-07T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/dovobet-ointment-approved-to-treat-psoriasis-vulgaris-070714-4311570/ 2014-07-07T05:22:00+00:00 https://www.pharmaceutical-business-review.com/news/japan-clears-anoro-ellipta-umeclidiniumvilanterol-for-copd-treatment-070714-4311582/ 2014-07-07T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/hospira-acquires-orchids-active-pharmaceutical-ingredient-manufacturing-and-rd-facility-070714-4311594/ 2014-07-07T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/us-raises-concern-over-secret-trial-of-two-gsk-investigators-in-china-070714-4311952/ 2014-07-07T06:47:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-committee-issues-positive-opinion-for-tevas-contraceptive-drug-seasonique-070714-4311971/ 2014-07-07T07:06:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-gets-ec-approval-of-indication-expansion-for-halaven-to-treat-breast-cancer-070714-4311984/ 2014-07-07T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-oxford-university-partner-for-new-gynecological-therapies-070714-4312013/ 2014-07-07T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-gets-eu-marketing-approval-for-melanoma-drug-mekinist-070714-4312065/ 2014-07-07T08:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibbs-combination-drug-for-hepatitis-c-treatment-gets-japanese-approval-080714-4312262/ 2014-07-07T23:42:00+00:00 https://www.pharmaceutical-business-review.com/news/regenerx-partner-g-treebnt-gears-up-for-phase-iii-dry-eye-trials-with-rgn-259-080714-4312499/ 2014-07-08T03:36:00+00:00 https://www.pharmaceutical-business-review.com/news/portola-daiichi-sankyo-collaborate-for-phase-iii-studies-of-factor-xa-inhibitor-antidote-080714-4312622/ 2014-07-08T03:41:00+00:00 https://www.pharmaceutical-business-review.com/news/cortice-biosciences-starts-enrolling-patients-in-phase-i-trial-of-tpi-287-080714-4312730/ 2014-07-08T03:46:00+00:00 https://www.pharmaceutical-business-review.com/news/orgenesis-masthercell-to-scale-manufacturing-of-insulin-producing-liver-cells-080714-4312886/ 2014-07-08T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/q-therapeutics-gets-first-us-patent-relating-to-fifth-patent-family-on-neural-cells-070814-4312910/ 2014-07-08T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/endo-biodelivery-report-positive-top-line-results-from-phase-iii-trial-of-bema-buprenorphine-080714-4312681/ 2014-07-08T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/yabao-pharma-eli-lilly-to-jointly-develop-diabetes-treatment-080714-4312825/ 2014-07-08T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/beigene-enrolls-first-patient-in-phase-i-trial-of-bgb-290-080714-4312684/ 2014-07-08T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/mariel-to-acquire-strykers-bmp-7-assets-for-potential-use-in-osteoarthritis-organ-fibrosis-080714-4312690/ 2014-07-08T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/biomarin-gets-health-canada-approval-of-vimizim-to-treat-morquio-a-syndrome-080714-4312736/ 2014-07-08T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/cliniworks-pfizer-to-develop-population-health-management-platform-080714-4312695/ 2014-07-08T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/compugen-discloses-achievement-of-milestone-in-cancer-immunotherapy-collaboration-with-bayer-080714-4312721/ 2014-07-08T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/gelstat-acquires-mastix-medica-for-restricted-common-stock-090714-4313772/ 2014-07-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-sanofis-nda-for-diabetes-drug-toujeo-090714-4313427/ 2014-07-08T23:38:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-confirms-generic-ampyra-patent-challenge-090714-4313778/ 2014-07-09T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/cynapsus-therapeutics-awarded-second-grant-from-the-michael-j-fox-foundation-for-parkinsons-research-090714-4313795/ 2014-07-09T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cannabis-therapy-commences-research-to-support-development-of-hemp-based-anti-inflammatory-products-090714-4313806/ 2014-07-09T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/iroko-pharmaceuticals-announces-first-international-filing-for-zorvolex-090714-4313811/ 2014-07-09T04:32:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-gets-fda-final-approval-for-store-brand-equivalent-to-advil-congestion-relief-tablets-090714-4314088/ 2014-07-09T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/sirnaomics-strengthens-ip-position-for-advancing-novel-sirna-therapeutics-programs-090714-4313817/ 2014-07-09T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-to-eagles-bendamustine-hcl-to-treat-cll-and-nhl-090714-4314202/ 2014-07-09T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/isco-inks-deal-including-certain-terms-for-definitive-license-agreement-with-rohto-090714-4314314/ 2014-07-09T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/purdue-gets-fda-priority-review-designation-for-hydrocodone-bitartrate-tablets-090714-4314358/ 2014-07-09T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/sunesis-gets-ema-acceptance-of-pediatric-investigation-plan-for-qinprezo-to-treat-aml-100714-4315903/ 2014-07-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/threshold-starts-dosing-in-phase-iii-trial-of-myeloma-combination-drug-th-302bortezomib-100714-4316788/ 2014-07-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-files-nda-to-fda-for-isavuconazole-to-treat-zygomycosis-100714-4314686/ 2014-07-09T23:51:00+00:00 https://www.pharmaceutical-business-review.com/news/par-pharmaceutical-begins-shipment-of-fluphenazine-decanoate-injection-usp-100714-4314948/ 2014-07-10T03:54:00+00:00 https://www.pharmaceutical-business-review.com/news/opkos-factor-viia-ctp-gets-positive-opinion-for-three-orphan-drug-designations-in-europe-100714-4314955/ 2014-07-10T03:55:00+00:00 https://www.pharmaceutical-business-review.com/news/lightlake-inks-deal-with-contract-manufacturer-for-naloxone-to-treat-opioid-overdose-100714-4315088/ 2014-07-10T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/delmar-pharmaceuticals-receives-funding-from-canadian-federal-government-100714-4314969/ 2014-07-10T04:26:00+00:00 https://www.pharmaceutical-business-review.com/news/humanetics-gets-new-grant-to-assess-treatment-for-ed-in-prostate-cancer-patients-100714-4314962/ 2014-07-10T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/nuvilex-scheduled-to-begin-preclinical-studies-in-early-august-100714-4314984/ 2014-07-10T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/alkermes-gets-notices-of-allowance-for-us-patents-for-four-cns-pipeline-candidates-100714-4315002/ 2014-07-10T04:32:00+00:00 https://www.pharmaceutical-business-review.com/news/lexicon-jdrf-partner-for-phase-ii-trial-of-lx4211-to-treat-type-1-diabetes-100714-4315554/ 2014-07-10T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/rosetta-genomics-gets-notice-of-allowance-for-us-patent-to-treat-ovarian-cancer-110714-4315964/ 2014-07-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/kythera-gets-fda-acceptance-for-atx-101-new-drug-application-110714-4316766/ 2014-07-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-to-submit-bla-in-us-for-melanoma-drug-opdivo-110714-4315712/ 2014-07-10T23:12:00+00:00 https://www.pharmaceutical-business-review.com/news/galderma-finalizes-major-expansion-in-aesthetic-and-corrective-dermatology-in-us-canada-110714-4315949/ 2014-07-11T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/acres-inventiv-health-to-promote-global-clinical-research-platform-110714-4315958/ 2014-07-11T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/palatin-technologies-gets-notification-of-patent-allowance-on-melanocortin-receptor-1-specific-peptides-110714-4315972/ 2014-07-11T04:43:00+00:00 https://www.pharmaceutical-business-review.com/news/prometic-to-commercially-launch-fibrinogen-in-q4-2014-110714-4315980/ 2014-07-11T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/verde-media-group-to-launch-proprietary-deep-well-fermentation-technology-for-omega-3-production-in-asia-110714-4315990/ 2014-07-11T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/kaleo-makes-opioid-overdose-drug-evzio-available-in-us-110714-4316457/ 2014-07-11T07:01:00+00:00 https://www.pharmaceutical-business-review.com/news/hd-biosciences-marshall-university-enter-drug-discovery-co-development-deal-110714-4316469/ 2014-07-11T07:09:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-grants-orphan-drug-status-to-zafgen-for-beloranib-to-treat-pws-110714-4316514/ 2014-07-11T08:20:00+00:00 https://www.pharmaceutical-business-review.com/news/sunovion-gets-canadian-approval-for-aptiom-to-treat-partial-onset-seizures-140714-4316666/ 2014-07-13T23:43:00+00:00 https://www.pharmaceutical-business-review.com/news/brightfocus-announces-55-new-grant-recipients-for-alzheimers-and-vision-disease-research-140714-4317009/ 2014-07-14T04:16:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-confirms-generic-diclegis-patent-challenge-140714-4317033/ 2014-07-14T04:17:00+00:00 https://www.pharmaceutical-business-review.com/news/ipsen-galderma-become-exclusive-partners-for-development-and-marketing-of-neurotoxins-140714-4317040/ 2014-07-14T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/helix-biopharma-announces-completion-of-private-placement-140714-4317065/ 2014-07-14T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/adocia-to-start-phase-iia-clinical-study-of-hinsbet-in-type-1-diabetes-140714-4317175/ 2014-07-14T04:53:00+00:00 https://www.pharmaceutical-business-review.com/news/prostrakan-agrees-to-acquire-archimedes-pharma-140714-4317251/ 2014-07-14T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-pasteur-releases-positive-results-from-phase-iii-dengue-vaccine-trial-140714-4317157/ 2014-07-14T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/genticels-phase-ii-study-with-procervix-passes-the-halfway-mark-for-patient-recruitment-140714-4317271/ 2014-07-14T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/roches-phase-iii-trial-of-melanoma-combination-therapy-meets-primary-endpoint-140714-4317310/ 2014-07-14T06:55:00+00:00 https://www.pharmaceutical-business-review.com/news/codexis-gsk-enter-into-technology-collaboration-license-agreement-150714-4318418/ 2014-07-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/medac-gets-fda-approval-for-rasuvo-injection-to-treat-rheumatoid-arthritis-pjia-and-psoriasis-150714-4318479/ 2014-07-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-agrees-to-buy-non-us-specialty-branded-generics-assets-from-abbott-for-53bn-150714-4318830/ 2014-07-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/trevi-therapeutics-starts-pivotal-study-of-nalbuphine-er-in-hemodialysis-patients-150714-4317605/ 2014-07-14T23:44:00+00:00 https://www.pharmaceutical-business-review.com/news/upsher-smith-launches-generic-equivalent-to-qudexy-xr-extended-release-capsules-150714-4317977/ 2014-07-15T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/genmab-to-receive-milestone-payment-in-duobody-platform-collaboration-with-janssen-150714-4317912/ 2014-07-15T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/anthera-acquires-sollpura-for-exocrine-pancreatic-insufficiency-from-eli-lilly-150714-4317926/ 2014-07-15T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/targacept-phase-iib-trial-in-alzheimers-disease-fails-to-show-superiority-of-tc-1734-over-donepezil-150714-4317935/ 2014-07-15T04:22:00+00:00 https://www.pharmaceutical-business-review.com/news/hemispherx-biopharma-bioclones-join-forces-on-novel-therapeutic-cancer-vaccine-150714-4317947/ 2014-07-15T04:23:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-salixs-relistor-subcutaneous-injection-snda-150714-4317960/ 2014-07-15T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-tevas-nda-for-albuterol-mdpi-150714-4318126/ 2014-07-15T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/otsuka-lundbeck-file-nda-for-brexpiprazole-to-treat-schizophrenia-and-mdd-150714-4318297/ 2014-07-15T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-sbla-grants-priority-review-for-genentechs-cervical-cancer-therapy-avastin-plus-160714-4318707/ 2014-07-15T23:43:00+00:00 https://www.pharmaceutical-business-review.com/news/bial-moksha8-partner-to-commercialize-eslicarbazepine-acetate-in-brazil-and-mexico-160714-4319100/ 2014-07-16T03:20:00+00:00 https://www.pharmaceutical-business-review.com/news/makers-of-otc-medicines-respond-to-pediatrics-study-on-units-of-measurement-on-liquid-medicines-160714-4319082/ 2014-07-16T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-designates-opioid-overdose-treatment-for-fast-track-development-program-160714-4319056/ 2014-07-16T04:32:00+00:00 https://www.pharmaceutical-business-review.com/news/banner-alzheimers-institute-partners-with-novartis-in-new-study-of-alzheimers-prevention-treatments-160714-4319064/ 2014-07-16T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/cvspharmacy-launches-exclusive-radiance-platinum-line-of-preservative-free-vitamins-and-supplements-160714-4319074/ 2014-07-16T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/celsion-announces-commercialization-of-reagent-products-160714-4319121/ 2014-07-16T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/pendopharm-gets-health-canada-approval-for-hepatitis-c-drug-ibavyr-160714-4319522/ 2014-07-16T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/iroko-pharmaceuticals-ems-collaborate-to-commercialize-zorvolex-in-brazil-160714-4319485/ 2014-07-16T06:32:00+00:00 https://www.pharmaceutical-business-review.com/news/harlan-fluofarma-partner-to-strengthen-drug-discovery-translational-medicine-services-160714-4319449/ 2014-07-16T06:33:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-for-medivirs-snda-for-olysio-sofosbuvir-combination-160714-4319424/ 2014-07-16T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/zs-pharma-completes-patient-enrollment-in-phase-iii-trial-of-hyperkalemia-treatment-160714-4319327/ 2014-07-16T06:36:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-pozens-nda-for-pa8140pa32540-tablets-170714-4319872/ 2014-07-16T23:52:00+00:00 https://www.pharmaceutical-business-review.com/news/chromadex-begins-first-human-clinical-study-to-confirm-chromadexs-niagen-nicotinamide-riboside-will-increase-nad-170714-4320274/ 2014-07-17T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/imquest-to-initiate-clinical-trials-of-a-vaginal-gel-for-the-prevention-of-hiv-transmission-to-women-170714-4320295/ 2014-07-17T04:06:00+00:00 https://www.pharmaceutical-business-review.com/news/isis-pharmaceuticals-earns-1-million-from-gsk-for-advancing-isis-ttr-rx-170714-4320252/ 2014-07-17T04:08:00+00:00 https://www.pharmaceutical-business-review.com/news/mediwound-announces-nexobrid-marketing-approval-from-israeli-ministry-of-health-170714-4320258/ 2014-07-17T04:09:00+00:00 https://www.pharmaceutical-business-review.com/news/basilea-seeks-european-approval-for-isavuconazole-to-treat-invasive-mold-infections-170714-4320283/ 2014-07-17T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/biolinerx-reports-results-from-phase-12-study-for-celiac-treatment-170714-4320267/ 2014-07-17T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/mymetics-to-manufacture-imugenes-virosome-based-her-vaxx-cancer-immunotherapy-170714-4320751/ 2014-07-17T06:39:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-immunocore-to-jointly-discover-and-develop-new-cancer-therapies-170714-4320832/ 2014-07-17T07:26:00+00:00 https://www.pharmaceutical-business-review.com/news/adynxx-begins-phase-ii-trial-of-ayx1-for-prevention-of-post-surgical-pain-170714-4320863/ 2014-07-17T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-gets-fda-breakthrough-status-for-ipf-treatment-for-nintedanib-170714-4320898/ 2014-07-17T08:35:00+00:00 https://www.pharmaceutical-business-review.com/news/octapharma-gets-fda-approval-for-immune-thrombocytopenic-purpura-therapy-octagam-10-170714-4320914/ 2014-07-17T08:45:00+00:00 https://www.pharmaceutical-business-review.com/news/oncomed-initiates-phase-2-alpine-clinical-trial-of-tarextumab-180714-4321135/ 2014-07-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/isis-pharmaceuticals-initiates-phase-2-study-of-isis-apoa-rx-in-patients-with-high-lpa-180714-4321176/ 2014-07-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/glenmark-pharma-to-build-new-manufacturing-plant-in-us-180714-4321760/ 2014-07-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-pfizer-begin-patient-enrollment-in-phase-iv-emanate-trial-of-eliquis-180714-4321021/ 2014-07-17T22:43:00+00:00 https://www.pharmaceutical-business-review.com/news/integral-molecular-announces-patent-allowance-for-dengue-research-technology-180714-4321098/ 2014-07-17T23:43:00+00:00 https://www.pharmaceutical-business-review.com/news/auspex-begins-pivotal-phase-23-clinical-trial-for-sd-809-in-tardive-dyskinesia-180714-4321121/ 2014-07-17T23:44:00+00:00 https://www.pharmaceutical-business-review.com/news/myos-enters-into-rd-agreement-with-cloud-pharmaceuticals-180714-4321161/ 2014-07-17T23:45:00+00:00 https://www.pharmaceutical-business-review.com/news/viacyte-files-investigational-new-drug-application-and-device-master-file-with-fda-for-novel-cell-replacement-therapy-product-candidate-designed-to-treat-patients-with-type-1-diabetes-180714-4321109/ 2014-07-18T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/alkermes-begins-phase-i-trial-of-alks-8700-to-treat-multiple-sclerosis-180714-4321431/ 2014-07-18T01:25:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-releases-positive-results-from-phase-iii-trial-of-benefix-to-treat-hemophilia-b-180714-4321441/ 2014-07-18T01:37:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-agrees-to-buy-innopharma-for-360m-180714-4321444/ 2014-07-18T02:12:00+00:00 https://www.pharmaceutical-business-review.com/news/hpra-publishes-list-of-potential-medicines-to-be-sold-without-prescription-210714-4324486/ 2014-07-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-to-start-phase-iii-trial-of-daratumumab-in-multiple-myeloma-in-q4-2014-210714-4321658/ 2014-07-20T23:20:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-reports-positive-phase-iii-results-for-amg-416-to-treat-secondary-hyperparathyroidism-in-ckd-patients-210714-4322068/ 2014-07-21T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/agile-therapeutics-announces-allowance-of-additional-patent-claims-for-skinfusion-210714-4322078/ 2014-07-21T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/cynapsus-therapeutics-commences-phase-ii-clinical-trials-in-us-210714-4322102/ 2014-07-21T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/purdue-pharma-gets-fda-approval-for-75-mcghour-dosage-strength-of-butrans-transdermal-system-ciii-210714-4322047/ 2014-07-21T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-gets-additional-patents-on-ylanthia-in-us-and-first-patent-in-china-210714-4322093/ 2014-07-21T04:39:00+00:00 https://www.pharmaceutical-business-review.com/news/rexahn-provides-update-on-phase-i-supinoxin-trial-in-cancer-patients-with-solid-tumors-210714-4322111/ 2014-07-21T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/durata-therapeutics-launches-dalvance-for-injection-in-us-210714-4322537/ 2014-07-21T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/lannett-inks-deal-with-symplmed-for-us-distribution-of-authorized-generic-of-aceon-210714-4322615/ 2014-07-21T08:02:00+00:00 https://www.pharmaceutical-business-review.com/news/regeneron-bayer-release-positive-phase-iii-trial-results-of-eylea-to-treat-dme-210714-4322671/ 2014-07-21T08:03:00+00:00 https://www.pharmaceutical-business-review.com/news/synergy-closes-patient-enrollment-in-phase-ii-trial-of-sp-333-in-patients-oic-210714-4322713/ 2014-07-21T08:04:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-avanirs-phase-ii-trial-of-mdd-candidate-avp-786-220714-4322944/ 2014-07-21T23:39:00+00:00 https://www.pharmaceutical-business-review.com/news/cti-biopharma-expands-access-to-pixuvri-with-approval-in-israel-220714-4323392/ 2014-07-22T03:56:00+00:00 https://www.pharmaceutical-business-review.com/news/celsion-gets-1m-nih-grant-for-glioblastoma-research-with-thermodox-and-hifu-220714-4323328/ 2014-07-22T03:59:00+00:00 https://www.pharmaceutical-business-review.com/news/celladon-announces-in-license-of-stem-cell-factor-development-program-220714-4323354/ 2014-07-22T04:00:00+00:00 https://www.pharmaceutical-business-review.com/news/tfs-selects-omnicomm-trialmaster-for-global-clinical-trial-research-220714-4323316/ 2014-07-22T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/harvard-medical-school-phelan-mcdermid-syndrome-foundation-contract-leverages-the-transmart-open-source-knowledge-management-platform-220714-4323369/ 2014-07-22T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/anacor-pharmaceuticals-sandoz-ink-deal-to-commercialize-kerydin-in-us-220714-4323339/ 2014-07-22T04:05:00+00:00 https://www.pharmaceutical-business-review.com/news/regulus-gets-fda-orphan-drug-status-for-rg-012-to-treat-alport-syndrome-220714-4323827/ 2014-07-22T07:39:00+00:00 https://www.pharmaceutical-business-review.com/news/arena-subsidiary-inks-marketing-supply-deal-with-abic-for-belviq-in-israel-220714-4323806/ 2014-07-22T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/anavex-receives-cgmp-manufacturing-for-drug-candidate-trial-supplies-220714-4323783/ 2014-07-22T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/advanced-bioscience-laboratories-acquires-majority-stake-in-platine-220714-4323587/ 2014-07-22T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/dipexium-enrols-first-patient-in-phase-iii-trials-of-locilex-220714-4323873/ 2014-07-22T08:35:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-university-of-toronto-form-alliance-for-new-therapeutic-concepts-in-ubiquitin-biology-230714-4323946/ 2014-07-22T22:52:00+00:00 https://www.pharmaceutical-business-review.com/news/taiho-pharmaceutical-invests-30m-in-remiges-biopharma-fund-230714-4324525/ 2014-07-23T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/galmed-gets-fda-clearance-of-ind-of-armachol-to-treat-fatty-liver-disorders-230714-4324535/ 2014-07-23T04:32:00+00:00 https://www.pharmaceutical-business-review.com/news/opko-granted-patent-from-us-patent-trademark-office-for-rayaldee-230714-4324564/ 2014-07-23T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-gets-notice-of-allowance-from-uspto-for-new-patent-broadly-covering-conjugate-based-delivery-of-rna-therapeutics-230714-4324554/ 2014-07-23T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/tute-genomics-biomarker-discovery-platform-to-support-byus-alzheimers-disease-genetics-research-230714-4324584/ 2014-07-23T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-genentechs-avastin-priority-review-for-recurrent-platinum-resistant-ovarian-cancer-230714-4324611/ 2014-07-23T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/galena-biopharma-inks-licensing-deal-with-monosol-rx-for-us-rights-of-zuplenz-4325122/ 2014-07-23T08:15:00+00:00 https://www.pharmaceutical-business-review.com/news/iroko-pharmaceuticals-calox-partner-to-commercialize-zorvolex-in-latin-america-230714-4325015/ 2014-07-23T08:16:00+00:00 https://www.pharmaceutical-business-review.com/news/antares-starts-dosing-in-phase-iii-quickshot-trial-evaluating-testosterone-deficient-adult-males-230714-4325046/ 2014-07-23T08:16:00+00:00 https://www.pharmaceutical-business-review.com/news/puma-biotechnology-revises-neratinib-licensing-deal-with-pfizer-230714-4324936/ 2014-07-23T08:17:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-enters-into-immuno-oncology-collaboration-with-ono-pharmaceutical-240714-4325415/ 2014-07-23T23:28:00+00:00 https://www.pharmaceutical-business-review.com/news/armagen-shire-to-develop-agt-182-for-treatment-of-hunter-syndrome-240714-4325867/ 2014-07-24T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/mezzion-pharma-begins-clinical-development-program-to-evaluate-udenafil-in-adolescents-with-single-ventricle-heart-defects-240714-4325881/ 2014-07-24T04:26:00+00:00 https://www.pharmaceutical-business-review.com/news/essentialis-gets-foundation-for-prader-willi-research-grant-to-help-advance-dccr-for-prader-willi-syndrome-240714-4325890/ 2014-07-24T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/sinovac-receives-beijing-cdc-tender-to-supply-seasonal-flu-vaccine-anflu-240714-4325903/ 2014-07-24T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/biosceptre-reports-positive-phase-i-results-for-bil-010t-to-treat-basal-cell-carcinoma-240714-4325949/ 2014-07-24T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/welichem-enters-into-termination-agreement-with-celestial-and-bwtp-240714-4325959/ 2014-07-24T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/lightlake-therapeutics-files-ind-application-for-naloxone-opioid-overdose-nasal-spray-240714-4326413/ 2014-07-24T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-idecs-multiple-sclerosis-drug-plegridy-gets-european-approval-240714-4326382/ 2014-07-24T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/neurotrope-mount-sinai-to-develop-bryostatin-1-for-npc-treatment-240714-4326482/ 2014-07-24T08:02:00+00:00 https://www.pharmaceutical-business-review.com/news/biosyent-signs-licensing-deal-for-new-urgent-care-drug-product-240714-4326474/ 2014-07-24T08:03:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-eagles-malignant-hyperthermia-treatment-ryanodex-240714-4326469/ 2014-07-24T08:05:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-files-regulatory-application-in-europe-for-malaria-vaccine-250714-4326720/ 2014-07-24T23:44:00+00:00 https://www.pharmaceutical-business-review.com/news/kinex-announces-allowance-of-ind-application-for-kx2-391-ointment-by-usfda-250714-4327092/ 2014-07-25T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/onco360-named-to-zydelig-limited-distribution-network-250714-4327157/ 2014-07-25T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/wirb-copernicus-acqures-alliance-biosciences-250714-4327169/ 2014-07-25T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-introduces-new-similac-breastfeeding-supplement-with-dha-lutein-and-vitamin-e-250714-4327178/ 2014-07-25T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/myos-gets-notice-of-allowance-of-us-patent-application-for-manufacturing-methods-of-fortetropin-250714-4327198/ 2014-07-25T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/national-institute-of-allergy-and-infectious-diseases-awards-sri-international-contract-to-study-new-therapies-for-hiv-and-aids-250714-4327136/ 2014-07-25T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/gsks-over-the-counter-spray-flonase-gets-fda-approval-250714-4327520/ 2014-07-25T07:50:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-gets-ab-therapeutic-equivalent-rating-from-fda-for-testosterone-gel-10-250714-4327527/ 2014-07-25T07:51:00+00:00 https://www.pharmaceutical-business-review.com/news/macrogenics-ind-for-colorectal-cancer-drug-candidate-mgd007-gets-fda-approval-250714-4327540/ 2014-07-25T07:52:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-enrols-first-patient-in-phase-iii-trial-of-letermovir-for-prevention-of-cmv-infection-250714-4327568/ 2014-07-25T08:24:00+00:00 https://www.pharmaceutical-business-review.com/news/prometic-biosciences-enters-into-new-product-development-program-250714-4327549/ 2014-07-25T13:24:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-committee-recommends-full-approval-of-imbruvica-to-treat-two-blood-cancers-280714-4327688/ 2014-07-27T23:02:00+00:00 https://www.pharmaceutical-business-review.com/news/european-chmp-adopts-positive-opinion-for-gileads-zydelig-to-treat-chronic-lymphocytic-leukemia-and-follicular-lymphoma-280714-4328029/ 2014-07-28T04:22:00+00:00 https://www.pharmaceutical-business-review.com/news/novogen-and-cantx-appoint-contract-manufacturers-to-produce-clinical-batches-of-cantrixil-280714-4328045/ 2014-07-28T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/transcelerate-selects-cognizant-to-develop-a-clinical-trials-collaboration-platform-280714-4328053/ 2014-07-28T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/myos-extends-manufacturing-supply-agreement-for-fortetropin-280714-4328094/ 2014-07-28T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/bioasis-releases-quantitative-results-sirna-transcendpep-reduces-target-gene-expression-in-the-brain-280714-4328065/ 2014-07-28T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-takeover-could-save-abbvie-8-billion-tax-on-humira-over-next-15-years-say-globaldata-analysts-280714-4328406/ 2014-07-28T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-onyx-report-results-from-phase-iii-breast-cancer-trial-of-sorafenib-280714-4328571/ 2014-07-28T07:20:00+00:00 https://www.pharmaceutical-business-review.com/news/first-patient-enrolled-in-reatas-phase-ii-trial-of-rta-408-to-treat-radiation-dermatitis-280714-4328553/ 2014-07-28T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/chmp-recommends-allergans-ozurdex-to-treat-diabetic-macular-edema-280714-4328514/ 2014-07-28T07:26:00+00:00 https://www.pharmaceutical-business-review.com/news/lion-moffitt-cancer-center-partner-to-improve-tumor-infiltrating-lymphocyte-production-280714-4328453/ 2014-07-28T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/alimera-iluvien-gets-marketing-authorization-in-norway-to-treat-chronic-dme-290714-4328825/ 2014-07-28T23:47:00+00:00 https://www.pharmaceutical-business-review.com/news/diplomat-receives-distribution-contract-for-zydelig-290714-4328907/ 2014-07-29T04:08:00+00:00 https://www.pharmaceutical-business-review.com/news/intended-sale-of-penn-pharma-business-to-packaging-coordinators-290714-4328915/ 2014-07-29T04:10:00+00:00 https://www.pharmaceutical-business-review.com/news/the-upsher-smith-galaxy-portfolio-of-antiepileptic-drugs-now-available-290714-4328921/ 2014-07-29T04:11:00+00:00 https://www.pharmaceutical-business-review.com/news/quark-reports-favorable-results-from-phase-ii-clinical-trial-evaluating-investigational-sirna-qpi-1002-290714-4328926/ 2014-07-29T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/alphaeon-acquires-physician-recommended-nutriceuticals-290714-4328929/ 2014-07-29T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/advaxis-receives-notice-of-allowance-for-cancer-immunotherapies-patent-in-japan-290714-4328935/ 2014-07-29T04:15:00+00:00 https://www.pharmaceutical-business-review.com/news/zealand-boehringer-to-advance-new-peptide-medicines-290714-4329136/ 2014-07-29T06:52:00+00:00 https://www.pharmaceutical-business-review.com/news/redbiotec-ge-healthcare-to-advance-cmv-vaccine-development-290714-4329142/ 2014-07-29T06:52:00+00:00 https://www.pharmaceutical-business-review.com/news/flexion-swri-ink-license-deal-for-proprietary-microsphere-manufacturing-technologies-290714-4329146/ 2014-07-29T06:52:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-gets-european-approval-for-leukemia-treatment-gazyvaro-300714-4329350/ 2014-07-29T23:19:00+00:00 https://www.pharmaceutical-business-review.com/news/erytech-enrolls-first-patient-in-phase-ii-study-of-ery-asp-in-pancreatic-cancer-300714-4329753/ 2014-07-30T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/eastgate-expands-pharmaceutical-developments-with-sub-micron-platform-technology-300714-4329824/ 2014-07-30T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/ryogen-awarded-two-patents-directed-to-polynucleotide-sequences-300714-4329758/ 2014-07-30T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/inergetics-completes-phase-i-development-of-therapeutic-cbd-line-of-products-300714-4329771/ 2014-07-30T04:39:00+00:00 https://www.pharmaceutical-business-review.com/news/cellectis-sells-swedish-subsidiary-cellectis-to-takara-bio-300714-4329854/ 2014-07-30T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/sunshine-biopharma-forms-canadian-subsidiary-300714-4329872/ 2014-07-30T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-makes-tanzeum-available-in-us-300714-4330346/ 2014-07-30T08:01:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-fate-therapeutics-ind-for-prohema-in-inherited-metabolic-disorders-300714-4330379/ 2014-07-30T08:02:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-adamis-nda-for-epinephrine-pre-filled-syringe-300714-4330414/ 2014-07-30T08:03:00+00:00 https://www.pharmaceutical-business-review.com/news/burnet-artes-collaborate-to-develop-new-malaria-vaccine-300714-4330455/ 2014-07-30T08:04:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-bms-pfizers-eliquis-to-treat-dvt-pe-300714-4330473/ 2014-07-30T08:05:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-agrees-to-acquire-baxters-vaccines-business-for-635m-310714-4330707/ 2014-07-30T23:47:00+00:00 https://www.pharmaceutical-business-review.com/news/chmp-issues-positive-opinion-for-intravenous-formulation-of-mercks-noxafil-310714-4331081/ 2014-07-31T03:45:00+00:00 https://www.pharmaceutical-business-review.com/news/lightlake-therapeutics-gets-funding-commitment-from-prominent-international-rd-foundation-310714-4331084/ 2014-07-31T03:45:00+00:00 https://www.pharmaceutical-business-review.com/news/pci-announces-definitive-agreement-to-acquire-penn-pharma-310714-4331091/ 2014-07-31T03:47:00+00:00 https://www.pharmaceutical-business-review.com/news/axxess-pharma-gets-2m-financing-to-fulfill-increased-rate-of-purchase-orders-310714-4331101/ 2014-07-31T03:47:00+00:00 https://www.pharmaceutical-business-review.com/news/theraclone-enters-into-agreement-with-gilead-sciences-for-broadly-neutralizing-hiv-antibodies-310714-4331111/ 2014-07-31T03:48:00+00:00 https://www.pharmaceutical-business-review.com/news/immune-pharmaceuticals-begins-patient-screening-for-bertilimumab-phase-ii-clinical-trial-in-bullous-pemphigoid-310714-4331148/ 2014-07-31T03:48:00+00:00 https://www.pharmaceutical-business-review.com/news/bayers-eylea-gets-fda-approval-for-diabetic-macular-edema-treatment-310714-4330886/ 2014-07-31T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/incyte-genentech-to-assess-combination-of-two-new-cancer-immunotherapies-310714-4330962/ 2014-07-31T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/innopharma-launches-olanzapine-for-injection-10mgvial-in-canada-310714-4330989/ 2014-07-31T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/anika-therapeutics-medline-enter-commercialization-deal-for-hyalomatrix-310714-4331786/ 2014-07-31T09:18:00+00:00 https://www.pharmaceutical-business-review.com/news/angelini-to-commercialize-duratas-dalbavancin-in-certain-european-territories-russia-and-turkey-4331791/ 2014-07-31T09:18:00+00:00 https://www.pharmaceutical-business-review.com/news/transgenomic-announces-issuance-of-new-european-patent-covering-cold-pcr-technologies-010814-4332905/ 2014-07-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/alimera-iluvien-gets-marketing-authorization-in-denmark-for-dme-treatment-010814-4331984/ 2014-07-31T23:50:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-genmab-report-positive-interim-result-for-phase-iii-study-of-ofatumumab-010814-4332336/ 2014-08-01T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/catylix-aspira-scientific-form-joint-venture-to-commercialize-new-fluorination-technologies-010814-4332346/ 2014-08-01T04:22:00+00:00 https://www.pharmaceutical-business-review.com/news/vertex-receives-european-approval-for-kalydeco-in-eight-non-g551d-gating-mutations-010814-4332351/ 2014-08-01T04:24:00+00:00 https://www.pharmaceutical-business-review.com/news/chromadex-signs-mta-with-australian-research-institute-for-niagen-research-010814-4332397/ 2014-08-01T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/cara-therapeutics-initiates-human-abuse-liability-trial-of-cr845-010814-4332408/ 2014-08-01T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/kala-pharmaceuticals-starts-phase-ii-trial-of-le-mpp-in-patients-with-rvo-dme-010814-4332734/ 2014-08-01T06:13:00+00:00 https://www.pharmaceutical-business-review.com/news/us-patent-office-gives-notice-of-allowance-to-mystic-for-powder-drug-delivery-technology-010814-4332746/ 2014-08-01T06:18:00+00:00 https://www.pharmaceutical-business-review.com/news/cortice-acquires-rights-to-new-neurological-disease-therapeutic-development-platform-010814-4332815/ 2014-08-01T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/ziopharm-solasia-pharma-ink-license-deal-for-darinaparsin-010814-4332891/ 2014-08-01T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-eli-lillys-diabetes-treatment-jardiance-gets-fda-approval-040814-4333183/ 2014-08-03T23:42:00+00:00 https://www.pharmaceutical-business-review.com/news/soligenix-secures-additional-niaid-funding-to-advance-development-of-orbeshield-in-gi-ars-040814-4333719/ 2014-08-04T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/amarantus-acquires-option-to-license-alzheimers-therapeutic-ip-of-dr-thomas-arendt-040814-4333732/ 2014-08-04T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/intellicell-biosciences-submits-pre-ind-to-fda-for-osteoarthritis-040814-4333747/ 2014-08-04T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/esperante-closes-acquisition-of-ophthalmology-firm-altacor-040814-4333757/ 2014-08-04T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-secures-approval-from-fda-for-label-expansion-of-lumizyme-in-us-040814-4333782/ 2014-08-04T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/xbiotech-begins-patient-enrollment-in-phase-iii-trial-of-xilonix-to-treat-colorectal-cancer-040814-4334043/ 2014-08-04T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/alexions-soliris-gets-orphan-drug-designation-from-european-commission-040814-4334013/ 2014-08-04T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringers-striverdi-respimat-inhalation-spray-gets-fda-approval-for-copd-treatment-040814-4333905/ 2014-08-04T07:27:00+00:00 https://www.pharmaceutical-business-review.com/news/ani-pharma-acquires-us-rights-of-vancocin-capsules-from-shire-040814-4333922/ 2014-08-04T07:27:00+00:00 https://www.pharmaceutical-business-review.com/news/isis-pharma-starts-phase-iii-isis-smn-trial-to-treat-spinal-muscular-atrophy-in-infants-040814-4334133/ 2014-08-04T07:48:00+00:00 https://www.pharmaceutical-business-review.com/news/cannabis-science-begins-pre-clinical-studies-on-cannabinoid-formulations-in-neurological-diseases-050814-4335305/ 2014-08-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cellular-biomedicine-acquires-immune-cell-therapy-technology-us-patent-050814-4334824/ 2014-08-05T04:23:00+00:00 https://www.pharmaceutical-business-review.com/news/infinity-pharmaceuticals-amends-pi3k-delta-gamma-agreement-with-millennium-050814-4334846/ 2014-08-05T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/ignyta-nerviano-sign-license-deal-for-two-first-in-class-kinase-inhibitors-050814-4334859/ 2014-08-05T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/oklahoma-multispecialty-divisions-us-oncology-network-partner-to-advance-cancer-care-050814-4334896/ 2014-08-05T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-agrees-to-acquire-santaris-pharma-for-450m-050814-4334312/ 2014-08-05T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/pernix-announces-closing-delayed-of-treximet-acquisition-from-gsk-050814-4335019/ 2014-08-05T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-re-inspects-impaxs-manufacturing-facility-in-hayward-050814-4335062/ 2014-08-05T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-allied-minds-form-new-research-enterprise-to-advance-biopharmaceutical-discoveries-050814-4335273/ 2014-08-05T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/sandoz-launches-apricus-vitaros-erectile-dysfunction-treatment-in-sweden-050814-4335258/ 2014-08-05T08:01:00+00:00 https://www.pharmaceutical-business-review.com/news/baxters-flexbumin-5-human-albumin-solution-gets-fda-approval-050814-4335234/ 2014-08-05T08:03:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvies-glioblastoma-multiforme-therapy-gets-orphan-drug-status-in-us-and-europe-050814-4335297/ 2014-08-05T08:09:00+00:00 https://www.pharmaceutical-business-review.com/news/kannalife-signs-new-license-agreement-with-nih-for-treatment-of-chronic-traumatic-encephalopathy-060814-4335963/ 2014-08-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/genoa-gets-orphan-drug-status-for-pirfenidone-to-treat-idiopathic-pulmonary-fibrosis-060814-4336668/ 2014-08-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/jazz-pharmaceuticals-acquires-worldwide-rights-to-vod-treatment-defibrotide-060814-4335507/ 2014-08-05T23:40:00+00:00 https://www.pharmaceutical-business-review.com/news/puramed-to-test-new-hemp-based-epilepsy-medication-060814-4336215/ 2014-08-06T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/biprousas-biozzz-instant-alpha-lactalbumin-supplement-gets-nsf-international-certification-060814-4335938/ 2014-08-06T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/inergetics-enters-second-phase-development-of-cbd-based-supplements-060814-4335952/ 2014-08-06T04:39:00+00:00 https://www.pharmaceutical-business-review.com/news/ariad-announces-commercial-agreement-for-iclusig-in-israel-060814-4335974/ 2014-08-06T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/kadimastem-to-collaborate-with-merck-serono-to-advance-combined-efforts-in-neurodegenerative-disease-area-060814-4335984/ 2014-08-06T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/certara-launches-d360-in-japan-to-improve-drug-discovery-and-development-productivity-060814-4335996/ 2014-08-06T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-snda-for-incytes-polycythemia-vera-treatment-jakafi-060814-4336619/ 2014-08-06T07:50:00+00:00 https://www.pharmaceutical-business-review.com/news/cubist-introduces-sivextro-iv-and-oral-formulations-in-us-for-absssi-treatment-060814-4336631/ 2014-08-06T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/roches-ovarian-cancer-treatment-avastin-gets-european-approval-070814-4336890/ 2014-08-06T23:42:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-charleston-to-develop-new-hydrocodone-products-070814-4337222/ 2014-08-07T04:02:00+00:00 https://www.pharmaceutical-business-review.com/news/mallinckrodt-announces-settlement-of-ofirmev-injection-patent-litigation-with-fresenius-kabi-070814-4337234/ 2014-08-07T04:06:00+00:00 https://www.pharmaceutical-business-review.com/news/endo-completes-acquisition-of-dava-pharmaceuticals-070814-4337241/ 2014-08-07T04:07:00+00:00 https://www.pharmaceutical-business-review.com/news/generex-announces-publication-of-ae37-prostate-cancer-vaccine-study-070814-4337244/ 2014-08-07T04:24:00+00:00 https://www.pharmaceutical-business-review.com/news/egalet-reports-topline-results-from-bioequivalence-studies-of-abuse-deterrent-morphine-070814-4337248/ 2014-08-07T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/idera-publish-promising-preclinical-data-targeting-microrna-with-gene-silencing-oligonucleotide-technology-070814-4337253/ 2014-08-07T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/trevena-starts-phase-i-trial-of-pain-drug-candidate-trv734-070814-4337427/ 2014-08-07T07:38:00+00:00 https://www.pharmaceutical-business-review.com/news/newlink-genetics-secures-ebola-vaccine-contract-from-us-dtra-070814-4337886/ 2014-08-07T07:39:00+00:00 https://www.pharmaceutical-business-review.com/news/yabao-changzhou-le-sun-pharmaceuticals-to-develop-early-stage-cancer-drugs-070814-4337925/ 2014-08-07T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/islet-sciences-gets-notice-of-allowance-from-uspto-for-new-il-12-inhibitors-070814-4337952/ 2014-08-07T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/cleardata-liaison-partner-to-expand-cloud-based-healthcare-solutions-070814-4337978/ 2014-08-07T07:44:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-seeks-ema-approval-for-new-indication-of-prevenar-13-vaccine-080814-4338117/ 2014-08-07T23:32:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-the-medicines-companys-orbactiv-to-treat-absssis-080814-4338747/ 2014-08-08T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/soligenix-advances-development-of-anthrax-vaccine-velothrax-080814-4338755/ 2014-08-08T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/nextsource-biotechnology-gains-fda-approval-for-use-of-tradename-gleostine-080814-4338760/ 2014-08-08T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-opens-first-facility-in-asia-announces-expansion-plans-with-new-processing-suite-080814-4338765/ 2014-08-08T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/oramed-reports-last-patient-out-in-phase-iia-trial-for-ormd-0801-in-type-1-diabetes-080814-4338776/ 2014-08-08T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/prostrakan-completes-acquisition-of-archimedes-080814-4338782/ 2014-08-08T04:50:00+00:00 https://www.pharmaceutical-business-review.com/news/igenica-gets-sbir-grant-to-develop-new-antibody-drug-conjugate-technology-080814-4339087/ 2014-08-08T07:05:00+00:00 https://www.pharmaceutical-business-review.com/news/cannabis-science-in-final-negotiations-to-set-up-first-medical-cannabis-facilities-in-canada-080814-4339104/ 2014-08-08T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/neurovance-completes-patient-enrollment-in-hal-study-for-centanafadine-to-treat-adhd-080814-4339139/ 2014-08-08T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/idera-tma-to-advance-clinical-development-of-myositis-treatment-080814-4339174/ 2014-08-08T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/alexza-pharmaceuticals-launches-adasuve-in-guatemala-110814-4341705/ 2014-08-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/tvm-life-supports-faah-pharma-in-new-neuropathic-pain-treatment-110814-4340382/ 2014-08-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/invivo-therapeutics-receives-notice-of-allowance-on-patent-covering-neuro-spinal-scaffold-and-neuro-spinal-scaffold-plus-stem-cells-110814-4341433/ 2014-08-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/engeneic-receives-patent-from-uspto-for-edv-nanocell-technology-110814-4341447/ 2014-08-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/global-holdings-acquires-infusive-technologies-110814-4341628/ 2014-08-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cureduchenne-prosensa-to-advance-access-to-treatments-for-duchenne-muscular-dystrophy-patients-110814-4341641/ 2014-08-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/avillion-doses-first-patients-in-phase-iii-bfore-trial-of-bosulif-to-treat-cml-110814-4341679/ 2014-08-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithklines-ebola-vaccine-may-enter-clinical-trials-soon-110814-4339539/ 2014-08-10T23:54:00+00:00 https://www.pharmaceutical-business-review.com/news/sun-pharma-likely-to-enter-japanese-market-in-four-years-110814-4339872/ 2014-08-11T02:45:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/eu-begins-pilot-on-decentralized-generic-drug-application-clearance-110814-4339941/ 2014-08-11T03:07:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-to-pay-up-to-900m-to-mannkind-for-share-in-insulin-afrezza-4340096/ 2014-08-11T03:58:00+00:00 https://www.pharmaceutical-business-review.com/news/retina-implants-alpha-ims-microchip-gets-approval-for-insurance-reimbursement-in-germany-4340213/ 2014-08-11T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/phosphagenics-completes-first-ind-enabling-tpmoxymorphone-patch-study-110814-4340395/ 2014-08-11T07:05:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-faces-new-drug-bribery-claims-in-syria-120814-4345592/ 2014-08-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/us-allows-use-of-experimental-zmapp-ebola-drug-in-liberia-120814-4340898/ 2014-08-11T23:37:00+00:00 https://www.pharmaceutical-business-review.com/news/freds-and-cardinal-health-announce-primary-supply-agreement-120814-4341487/ 2014-08-12T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/vgti-floridas-novel-vaccine-aims-to-stop-spread-of-chikungunya-virus-120814-4341519/ 2014-08-12T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/cubist-issues-voluntary-nationwide-recall-of-nine-lots-of-cubicin-500mg-in-10ml-single-use-vials-120814-4341549/ 2014-08-12T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/biodel-reports-positive-preliminary-results-from-phase-iia-trial-of-diabetes-drug-120814-4341584/ 2014-08-12T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-velcade-retreatment-in-patients-with-multiple-myeloma-120814-4341604/ 2014-08-12T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/sigma-tau-crosscare-ink-deal-for-marketing-distribution-of-colief-in-us-120814-4342072/ 2014-08-12T09:10:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-generic-xeloda-tablets-120814-4342075/ 2014-08-12T09:10:00+00:00 https://www.pharmaceutical-business-review.com/news/fresenius-kabi-launches-diprivan-injectable-emulsion-usp-in-10ml-vials-120814-4342079/ 2014-08-12T09:10:00+00:00 https://www.pharmaceutical-business-review.com/news/kythera-seeks-health-canada-approval-for-submental-fat-reduction-drug-120814-4342081/ 2014-08-12T09:10:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/quantitative-biology-approach-reveals-importance-of-physical-constraints-on-critical-dna-interaction-4343573/ 2014-08-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-starts-phase-i-trial-of-sgn-cd70a-to-treat-nhl-rcc-130814-4342309/ 2014-08-12T23:40:00+00:00 https://www.pharmaceutical-business-review.com/news/itonis-pharmaceuticals-announces-first-emesyl-manufacturer-production-release-date-130814-4342630/ 2014-08-13T04:17:00+00:00 https://www.pharmaceutical-business-review.com/news/arthritis-society-to-launch-pain-management-program-to-support-canadians-living-with-arthritis-130814-4342640/ 2014-08-13T04:18:00+00:00 https://www.pharmaceutical-business-review.com/news/cortendo-enrols-first-patient-in-phase-3-sonics-trial-130814-4342669/ 2014-08-13T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/novogen-secures-funding-to-start-studies-in-muscular-dystrophy-130814-4342682/ 2014-08-13T04:22:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-acquires-licensing-rights-for-artilysin-technology-from-lysando-130814-4342712/ 2014-08-13T04:22:00+00:00 https://www.pharmaceutical-business-review.com/news/evoke-pharma-begins-thorough-ecg-study-of-evk-001-in-women-with-diabetic-gastroparesis-130814-4343113/ 2014-08-13T07:54:00+00:00 https://www.pharmaceutical-business-review.com/news/protein-sciences-liomont-ink-licensing-deal-for-influenza-vaccines-in-mexico-130814-4343140/ 2014-08-13T07:56:00+00:00 https://www.pharmaceutical-business-review.com/news/oncosynergys-os2966-glioblastoma-treatment-gets-fda-orphan-drug-status-130814-4343157/ 2014-08-13T07:59:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-eylea-to-treat-diabetic-macular-edema-130814-4343218/ 2014-08-13T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-launches-generic-version-of-eloxatin-130814-4343239/ 2014-08-13T08:01:00+00:00 https://www.pharmaceutical-business-review.com/news/entia-biosciences-supplements-could-prevent-dementia-130814-4342656/ 2014-08-13T09:49:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-releases-top-line-results-from-phase-iii-programme-of-lesinurad-in-gout-patients-140814-4343513/ 2014-08-13T23:41:00+00:00 https://www.pharmaceutical-business-review.com/news/allergan-acquires-worldwide-rights-of-liris-program-from-taris-biomedical-140814-4344040/ 2014-08-14T04:26:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-issues-voluntary-recall-of-aranesp-500-mcg-prefilled-syringes-outside-us-140814-4343934/ 2014-08-14T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/reprogenetics-expands-to-southeast-with-miami-facility-140814-4343940/ 2014-08-14T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ohr-pharmaceutical-reports-additional-interim-data-from-phase-ii-trial-of-squalamine-eye-drops-140814-4343949/ 2014-08-14T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-pharma-gets-uspto-issues-additional-notice-of-allowance-for-vimovo-140814-4343960/ 2014-08-14T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/biocryst-gets-additional-niaid-funding-to-advance-development-of-bcx4430-140814-4343970/ 2014-08-14T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/tni-biotech-signs-supplemental-collaborative-agreement-with-hubei-qianjiang-pharmaceutical-130814-4343978/ 2014-08-14T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/redhill-biopharma-acquires-option-for-phase-ii-pancreatic-cancer-drug-rp101-140814-4343918/ 2014-08-14T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-b-brauns-nutrilipid-20-for-parenteral-nutrition-therapy-140814-4344292/ 2014-08-14T09:34:00+00:00 https://www.pharmaceutical-business-review.com/news/puramed-completes-first-production-of-migrapure-gel-140814-4344298/ 2014-08-14T09:34:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-status-for-agioss-ag-221-to-treat-aml-140814-4344302/ 2014-08-14T09:34:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-starts-phase-iii-program-for-asthma-drug-tralokinumab-150814-4344549/ 2014-08-14T23:13:00+00:00 https://www.pharmaceutical-business-review.com/news/miltenyi-biotec-acquires-gene-therapy-assets-from-lentigen-150814-4344579/ 2014-08-14T23:38:00+00:00 https://www.pharmaceutical-business-review.com/news/coherus-chs-1420-meets-primary-endpoint-in-pivotal-pharmacokinetic-clinical-study-150814-4344585/ 2014-08-14T23:38:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-pfizers-bla-for-meningococcal-b-vaccine-candidate-150814-4344662/ 2014-08-15T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/ligand-signs-license-deal-with-avion-for-captisol-150814-4344830/ 2014-08-15T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/trevi-therapeutics-gets-two-patents-for-nalbuphine-er-150814-4344913/ 2014-08-15T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/nodality-announces-us-patent-for-single-cell-network-profiling-technology-platform-150814-4344663/ 2014-08-15T05:13:00+00:00 https://www.pharmaceutical-business-review.com/news/immudyne-launches-clinical-study-of-patented-beta-glucan-technology-150814-4344668/ 2014-08-15T05:14:00+00:00 https://www.pharmaceutical-business-review.com/news/access-pharmaceuticals-awarded-japan-patent-for-mugard-and-proctigard-150814-4344671/ 2014-08-15T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/nuvilex-reports-combined-results-of-the-initial-phase-12-clinical-trial-and-second-phase-2-clinical-trial-of-cell-in-a-box-150814-4344675/ 2014-08-15T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/la-jolla-secures-notice-of-allowance-from-uspto-for-modified-pectin-to-treat-chronic-inflammation-150814-4344922/ 2014-08-15T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/roches-avastin-plus-chemotherapy-gets-fda-approval-for-cervical-cancer-treatment-180814-4345268/ 2014-08-18T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/mallinckrodt-completes-acquisition-of-questcor-pharmaceuticals-180814-4345692/ 2014-08-18T04:32:00+00:00 https://www.pharmaceutical-business-review.com/news/supernus-receives-fda-fast-track-designation-for-spn-810-180814-4345729/ 2014-08-18T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/acura-provides-update-on-fda-discussions-on-development-of-aversion-hydrocodone-with-acetaminophen-tablet-180814-4345724/ 2014-08-18T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/isis-pharmaceuticals-earns-2m-from-advancement-of-isis-smn-180814-4345754/ 2014-08-18T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/neurovive-continues-enrollment-in-phase-ii-study-on-neurostat-180814-4345766/ 2014-08-18T04:43:00+00:00 https://www.pharmaceutical-business-review.com/news/cyig-signs-strategic-cooperation-agreement-with-xian-putian-pharmacy-180814-4345781/ 2014-08-18T04:43:00+00:00 https://www.pharmaceutical-business-review.com/news/biogens-multiple-sclerosis-drug-plegridy-gets-fda-approval-180814-4346242/ 2014-08-18T08:09:00+00:00 https://www.pharmaceutical-business-review.com/news/pragma-pharmaceuticals-to-re-launch-once-daily-moxatag-180814-4346037/ 2014-08-18T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-status-for-agios-ag-221-to-treat-acute-myelogenous-leukemia-180814-4346211/ 2014-08-18T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/japans-chugai-pharmaceutical-denies-roche-takeover-reports-180814-4346353/ 2014-08-18T09:12:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-submits-nda-for-breast-cancer-treatment-palbociclib-to-fda-190814-4346413/ 2014-08-18T22:54:00+00:00 https://www.pharmaceutical-business-review.com/news/globavir-seeks-approval-to-develop-new-ebola-drug-190814-4346418/ 2014-08-18T23:09:00+00:00 https://www.pharmaceutical-business-review.com/news/eastgate-augments-sub-micron-self-nanoemulsifying-platform-technology-190814-4346432/ 2014-08-18T23:30:00+00:00 https://www.pharmaceutical-business-review.com/news/medicinova-releases-positive-interim-results-of-phase-iia-mn-166-study-in-opioid-dependence-190814-4346436/ 2014-08-18T23:33:00+00:00 https://www.pharmaceutical-business-review.com/news/fresenius-kabi-launches-acetylcysteine-solution-10-in-multiple-doses-190814-4346595/ 2014-08-19T03:46:00+00:00 https://www.pharmaceutical-business-review.com/news/pharpoint-research-wins-project-award-from-otologic-pharmaceuticals-190814-4346602/ 2014-08-19T03:55:00+00:00 https://www.pharmaceutical-business-review.com/news/provectus-signs-mou-with-sinopharm-csipi-and-sinopharm-a-think-190814-4346607/ 2014-08-19T03:59:00+00:00 https://www.pharmaceutical-business-review.com/news/apricus-biosciences-announces-launch-of-topical-treatment-for-erectile-dysfunction-vitaros-in-germany-by-hexal-190814-4346610/ 2014-08-19T04:02:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-agrees-to-acquire-15-stake-in-gamida-cell-200814-4347011/ 2014-08-19T23:53:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-cerdelga-for-type-1-gaucher-disease-treatment-200814-4347549/ 2014-08-20T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/novans-nitricil-technology-demonstrates-efficacy-against-multi-drug-resistant-pathogens-200814-4347560/ 2014-08-20T03:46:00+00:00 https://www.pharmaceutical-business-review.com/news/capsugel-and-cardax-to-collaborate-on-development-of-proprietary-astaxanthin-products-200814-4347429/ 2014-08-20T03:57:00+00:00 https://www.pharmaceutical-business-review.com/news/axxess-pharma-reports-increased-global-sales-200814-4347442/ 2014-08-20T03:58:00+00:00 https://www.pharmaceutical-business-review.com/news/7-keto-supplement-brand-sold-to-interhealth-200814-4347456/ 2014-08-20T03:58:00+00:00 https://www.pharmaceutical-business-review.com/news/immune-targeting-systems-and-wcct-global-announce-a-new-influenza-a-h1n1-virus-to-support-the-experimental-human-viral-challenge-model-200814-4347465/ 2014-08-20T03:59:00+00:00 https://www.pharmaceutical-business-review.com/news/clinigen-group-acquires-ethyol-amifostine-global-rights-from-astrazeneca-200814-4347478/ 2014-08-20T04:00:00+00:00 https://www.pharmaceutical-business-review.com/news/recipharm-to-buy-corvette-pharmaceutical-services-for-160m-200814-4347843/ 2014-08-20T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/us-doj-clears-astrazenecas-rigged-clinical-trial-200814-4347838/ 2014-08-20T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-lilly-and-boehringers-basaglar-insulin-glargine-injection-200814-4347824/ 2014-08-20T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-launches-generic-version-of-precedex-injection-200814-4347818/ 2014-08-20T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/tb-alliance-to-receive-drug-candidate-compounds-from-novartis-210814-4348348/ 2014-08-20T22:54:00+00:00 https://www.pharmaceutical-business-review.com/news/pernix-therapeutics-acquires-us-rights-for-treximet-210814-4348367/ 2014-08-20T22:55:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-gsks-arnuity-ellipta-to-treat-asthma-in-us-210814-4348383/ 2014-08-20T23:01:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-emergent-biosolutions-to-co-develop-and-commercialize-es414-210814-4348359/ 2014-08-21T00:12:00+00:00 https://www.pharmaceutical-business-review.com/news/regeneus-cryosite-to-jointly-manufacture-human-stem-cell-products-210814-4349294/ 2014-08-21T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-authorizes-kronus-znt8ab-elisa-assay-for-marketing-210814-4349300/ 2014-08-21T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-launches-emergency-research-to-help-battle-ebola-outburst-210814-4349322/ 2014-08-21T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/mitsubishi-tanabe-pharma-astrazeneca-partner-on-diabetic-nephropathy-research-210814-4349400/ 2014-08-21T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/lannett-agrees-to-purchase-two-generic-pharmaceutical-products-210814-4349381/ 2014-08-21T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/glenmark-starts-ind-enabling-studies-of-new-bispecific-antibody-210814-4349389/ 2014-08-21T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/paradigm-collaborates-with-tesaro-on-molecular-profiling-210814-4349647/ 2014-08-21T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-seeks-approval-to-expand-antiepilepsy-agent-fycompa-as-adjunctive-cure-of-primary-generalised-tonic-clonic-seizures-210814-4349649/ 2014-08-21T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-eliquis-for-dvt-and-pe-treatment-220814-4350008/ 2014-08-21T23:49:00+00:00 https://www.pharmaceutical-business-review.com/news/us-dea-tightens-restrictions-on-painkiller-prescriptions-220814-4350629/ 2014-08-22T04:52:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-mhra-approves-cbris-lifesciences-new-facility-220814-4350637/ 2014-08-22T04:53:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-plans-to-build-new-health-drink-units-in-andhra-pradesh-india-220814-4350643/ 2014-08-22T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/biospecifics-xiaflex-demonstrates-efficacy-in-phase-2a-cellulite-study-220814-4350933/ 2014-08-22T06:39:00+00:00 https://www.pharmaceutical-business-review.com/news/psc-investments-acquires-sterile-injectable-facility-from-mir-220814-4350737/ 2014-08-22T06:51:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-agrees-to-review-basileas-isavuconazole-marketing-authorization-application-220814-4350724/ 2014-08-22T06:52:00+00:00 https://www.pharmaceutical-business-review.com/news/lillys-ixekizumab-proves-superior-in-phase-3-psoriasis-studies-220814-4350942/ 2014-08-22T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-initiates-eap-for-palbociclib-in-us-220814-4350947/ 2014-08-22T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/sucampo-signs-exclusive-global-manufacturing-and-supply-deal-for-lubiprostone-220814-4351049/ 2014-08-22T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/dicerna-issues-multiple-patents-covering-claims-for-dicer-substrate-sirnas-220814-4351041/ 2014-08-22T07:38:00+00:00 https://www.pharmaceutical-business-review.com/news/auxilium-pharmaceuticals-achieves-positive-results-from-phase-2a-study-of-cch-in-patients-with-cellulite-220814-4351033/ 2014-08-22T07:39:00+00:00 https://www.pharmaceutical-business-review.com/news/biolinerx-receives-notice-of-allowance-for-us-patent-on-bl-7010-for-gluten-toxicity-220814-4351086/ 2014-08-22T07:49:00+00:00 https://www.pharmaceutical-business-review.com/news/advaxis-merck-collaborate-for-new-immune-therapies-for-prostate-cancer-treatment-250814-4352553/ 2014-08-24T14:00:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-agrees-to-acquire-intermune-for-83bn-250814-4351514/ 2014-08-24T23:46:00+00:00 https://www.pharmaceutical-business-review.com/news/new-clinical-study-evaluates-masimo-ram-technology-for-tracking-changes-in-respiratory-rate-in-anesthetized-patients-250814-4352123/ 2014-08-25T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/aldea-pharmaceuticals-closes-24m-series-b-financing-250814-4352130/ 2014-08-25T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-reports-positive-top-line-results-from-phase-iii-trial-of-bax-855-250814-4352137/ 2014-08-25T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/breedit-seach-form-kanaboseed-to-develop-new-medical-cannabis-varieties-250814-4352148/ 2014-08-25T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/vivus-acquires-topiramate-related-patents-from-janssen-pharmaceuticals-250814-4352364/ 2014-08-25T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-first-generic-klor-con-extended-release-tablets-for-hypokalemia-treatment-250814-4352306/ 2014-08-25T06:31:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-seeks-fda-approval-to-market-rotigotine-extended-release-transdermal-film-250814-4352173/ 2014-08-25T07:39:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-accepts-to-review-cubists-maa-for-ceftolozanetazobactam-250814-4352214/ 2014-08-25T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-viiv-healthcares-triumeq-to-treat-hiv-1-infection-250814-4352279/ 2014-08-25T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/alexion-starts-eculizumab-trail-for-post-kidney-replacement-dgf-prevention-260814-4352800/ 2014-08-25T23:38:00+00:00 https://www.pharmaceutical-business-review.com/news/cilag-international-acquires-biopharmaceutical-firm-covagen-260814-4353471/ 2014-08-26T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-irokos-zorvolex-for-osteoarthritis-pain-management-260814-4353533/ 2014-08-26T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/multicell-gets-us-patent-covering-therapeutics-which-fight-virus-infection-and-cancer-260814-4353553/ 2014-08-26T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/cardiome-eurolab-ink-deal-to-commercialize-brinavess-in-argentina-260814-4353966/ 2014-08-26T07:51:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-for-insys-cbd-to-treat-glioblastoma-multiforme-260814-4354005/ 2014-08-26T08:26:00+00:00 https://www.pharmaceutical-business-review.com/news/roches-spring-bioscience-introduces-pd-l1-ihc-antibody-for-immunotherapy-research-260814-4354012/ 2014-08-26T08:38:00+00:00 https://www.pharmaceutical-business-review.com/news/alkermes-submits-nda-to-fda-for-schizophrenia-drug-aripiprazole-lauroxil-260814-4354021/ 2014-08-26T08:47:00+00:00 https://www.pharmaceutical-business-review.com/news/civitas-therapeutics-gets-55m-series-c-financing-260814-4354024/ 2014-08-26T08:47:00+00:00 https://www.pharmaceutical-business-review.com/news/non-synthetic-growth-hormone-supplements-provide-otc-alternative-to-hgh-injections-260814-4354027/ 2014-08-26T08:54:00+00:00 https://www.pharmaceutical-business-review.com/news/neomed-secures-12m-from-canadian-government-260814-4354025/ 2014-08-26T08:55:00+00:00 https://www.pharmaceutical-business-review.com/news/lifestyle-nutrition-labs-to-unveil-drinkable-prenatal-vitamin-mommy-water-260814-4354028/ 2014-08-26T08:58:00+00:00 https://www.pharmaceutical-business-review.com/news/regado-biosciences-permanently-halts-regulate-pci-clinical-trial-270814-4358791/ 2014-08-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-glaxosmithklines-anaemia-drug-promacta-270814-4354225/ 2014-08-26T23:40:00+00:00 https://www.pharmaceutical-business-review.com/news/accenthealth-releases-otc-white-paper-on-physicians-role-in-otc-recommendations-purchasing-decisions-270814-4354658/ 2014-08-27T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ipsen-to-start-second-resupply-of-increlex-in-the-us-in-september-270814-4354670/ 2014-08-27T02:37:00+00:00 https://www.pharmaceutical-business-review.com/news/bavarian-nordic-secures-order-to-supply-imvamune-smallpox-vaccine-in-canada-270814-4354681/ 2014-08-27T02:43:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ab-sciex-dalton-pharma-partner-to-advance-antibody-drug-conjugate-analysis-270814-4354710/ 2014-08-27T02:56:00+00:00 https://www.pharmaceutical-business-review.com/news/recipharm-isofol-medical-collaborate-to-manufacture-modufolin-270814-4354707/ 2014-08-27T02:57:00+00:00 https://www.pharmaceutical-business-review.com/news/concert-pharma-secures-2m-payment-for-new-drug-product-avp-786-270814-4354917/ 2014-08-27T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-fresenius-kabis-kabiven-and-perikabiven-for-parenteral-nutrition-270814-4354860/ 2014-08-27T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-and-lilly-launch-type-2-diabetes-drug-jardiance-in-us-with-prescription-270814-4354770/ 2014-08-27T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/anavex-selects-alfred-hospital-as-lead-site-for-phase-iia-alzheimers-trial-270814-4355300/ 2014-08-27T06:49:00+00:00 https://www.pharmaceutical-business-review.com/news/sorrento-secures-nih-grant-to-advance-immunotherapy-for-ipf-treatment-270814-4355247/ 2014-08-27T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-approval-to-medicinova-to-begin-mn-166-trial-to-treat-als-270814-4355344/ 2014-08-27T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myerss-hcv-combination-therapy-gets-european-approval-280414-4355663/ 2014-08-27T23:44:00+00:00 https://www.pharmaceutical-business-review.com/news/vifor-pharmas-hyperphosphatemia-drug-velphoro-gets-marketing-authorisation-in-europe-280814-4356206/ 2014-08-28T04:39:00+00:00 https://www.pharmaceutical-business-review.com/news/amerigen-menovo-partner-to-develop-generic-pharmaceuticals-for-us-market-280814-4356237/ 2014-08-28T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/acura-gets-nih-grant-to-fund-new-limitx-abuse-deterrent-technology-280814-4356321/ 2014-08-28T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/repros-therapeutics-reports-top-line-results-of-androxal-from-first-of-two-pivotal-studies-280814-4356340/ 2014-08-28T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/madison-vaccines-mvi-816-to-be-used-in-clinical-trial-of-a-new-combination-to-treat-metastatic-prostate-cancer-280814-4356355/ 2014-08-28T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/ayasdi-introduces-care-application-for-healthcare-providers-to-develop-precise-clinical-pathways-280814-4356362/ 2014-08-28T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-notice-of-allowance-for-claims-in-alnylams-tuschl-patent-application-280814-4356439/ 2014-08-28T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/synexus-acquires-research-centre-in-south-africa-280814-4356442/ 2014-08-28T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/emd-millipore-expands-biomanufacturing-sciences-and-training-center-in-japan-280814-4356447/ 2014-08-28T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/amgens-nda-for-heart-failure-drug-ivabradine-gets-fda-priority-review-status-280814-4356522/ 2014-08-28T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/biothera-gets-nih-funding-to-further-develop-fungal-vaccine-280814-4356569/ 2014-08-28T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/innovus-and-danalife-ink-marketing-distribution-deal-for-zestra-in-alternative-markets-290814-4356804/ 2014-08-28T23:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-twi-pharmas-generic-megestrol-acetate-125mgml-oral-suspension-290814-4356809/ 2014-08-28T23:40:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-gets-fda-fast-track-status-for-c-difficile-vaccine-candidate-290814-4356810/ 2014-08-28T23:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-pfizer-and-protalixs-elelyso-to-treat-type-1-gaucher-disease-290814-4356797/ 2014-08-28T23:41:00+00:00 https://www.pharmaceutical-business-review.com/news/dpx-holdings-agrees-to-acquire-gallus-biopharmaceuticals-290814-4356815/ 2014-08-28T23:41:00+00:00 https://www.pharmaceutical-business-review.com/news/ibio-secures-european-patent-allowances-for-protein-expression-technology-290814-4356817/ 2014-08-28T23:43:00+00:00 https://www.pharmaceutical-business-review.com/news/immunotech-completes-phase-i-and-phase-ii-field-trials-of-patented-treatment-of-hivaids-and-hepatitis-c-viruses-290814-4356819/ 2014-08-28T23:47:00+00:00 https://www.pharmaceutical-business-review.com/news/china-food-and-drug-administration-approves-sciclone-and-btgs-dc-bead-290814-4356821/ 2014-08-28T23:51:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-reports-positive-top-line-results-from-phase-iii-trial-of-evolocumab-combination-290814-4356827/ 2014-08-29T00:01:00+00:00 https://www.pharmaceutical-business-review.com/news/momentas-anda-for-generic-copaxone-accepted-for-review-by-fda-290814-4356843/ 2014-08-29T02:26:00+00:00 https://www.pharmaceutical-business-review.com/news/pharma-cannot-deliver-patient-centricity-4460301/ 2014-08-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-reports-positive-results-for-lcz696-drug-to-treat-chronic-heart-disease-010914-4357340/ 2014-08-31T23:22:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-innopharmas-decitabine-for-injection-to-treat-myelodysplastic-syndromes-010914-4357979/ 2014-09-01T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/niaid-funds-biocrysts-non-human-primate-trial-of-bcx4430-to-treat-ebola-disease-010914-4358018/ 2014-09-01T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/dezima-releases-positive-phase-iib-ta-8995-trial-results-for-dyslipidemia-treatment-010914-4358060/ 2014-09-01T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-expands-explorer-research-program-to-evaluate-xarelto-010914-4358088/ 2014-09-01T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-qidp-status-for-wockhardt-anti-infective-drug-discovery-program-010914-4358110/ 2014-09-01T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-and-regeneron-report-positive-results-from-four-pivotal-alirocumab-trials-010914-4358134/ 2014-09-01T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-starts-tender-offer-for-intermune-for-74-per-share-in-cash-010914-4358154/ 2014-09-01T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-completes-post-marketing-commitment-to-submit-data-for-pioglitazone-containing-medicines-010914-4358197/ 2014-09-01T05:56:00+00:00 https://www.pharmaceutical-business-review.com/news/boston-scientific-reports-primary-endpoint-results-of-nectar-hf-trial-010914-4358396/ 2014-09-01T07:20:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-and-pfizer-report-positive-results-from-phase-iii-amplify-ext-trial-of-eliquis-010914-4358267/ 2014-09-01T07:21:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-ucbs-anti-epileptic-drug-vimpat-as-monotherapy-020914-4358705/ 2014-09-01T23:46:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-launches-type-2-diabetes-drug-ryzodegm-in-mexico-020914-4359194/ 2014-09-02T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/eddingpharm-to-develop-and-commercialise-ablynxs-ozoralizumab-in-china-020914-4359312/ 2014-09-02T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-for-ipsens-snda-of-somatuline-injection-to-treat-gep-nets-020914-4359367/ 2014-09-02T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringers-clinical-practice-and-expanding-research-program-supports-use-of-pradaxa-for-clot-prevention-020914-4359421/ 2014-09-02T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/biocrates-life-sciences-launches-metabolomics-based-bile-acids-kit-020914-4359450/ 2014-09-02T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-reports-results-from-phase-iv-atlantic-study-of-brilintabrilique-020914-4359478/ 2014-09-02T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/ventirx-gets-fda-fast-track-status-for-motolimod-to-treat-ovarian-cancer-020914-4359903/ 2014-09-02T07:54:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-for-arenas-hypertension-drug-candidate-apd811-020914-4359887/ 2014-09-02T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/orexigen-expands-nb32-intellectual-property-portfolio-with-new-us-patent-020914-4359913/ 2014-09-02T07:58:00+00:00 https://www.pharmaceutical-business-review.com/news/exelixis-reports-phase-iii-trial-results-of-prostate-cancer-drug-cabozantinib-020914-4359912/ 2014-09-02T08:03:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-breakthrough-therapy-status-for-acadias-nuplazid-030914-4361179/ 2014-09-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/japan-develops-30-minute-test-to-detect-ebola-virus-disease-030914-4360184/ 2014-09-02T23:42:00+00:00 https://www.pharmaceutical-business-review.com/news/allergans-ozurdex-gets-european-approval-to-treat-diabetic-macular-edema-030914-4360673/ 2014-09-03T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-for-filing-of-actavis-nda-for-eluxadoline-030914-4360725/ 2014-09-03T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/nutri-lifescience-rolls-out-new-bergamonte-product-030914-4361029/ 2014-09-03T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/cellular-biomedicine-launches-clinical-research-study-for-cartilage-defect-stem-cell-therapy-030914-4361037/ 2014-09-03T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/over-the-counter-pain-reliever-may-restore-immune-function-in-old-age-030914-4361045/ 2014-09-03T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/biolegend-acquires-covances-antibody-products-business-unit-030914-4361311/ 2014-09-03T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/macrocure-closes-patient-enrolment-in-phase-iii-curexcell-trial-to-treat-diabetic-foot-ulcers-030914-4361156/ 2014-09-03T07:48:00+00:00 https://www.pharmaceutical-business-review.com/news/emd-serono-mgh-partner-to-advance-lupus-research-030914-4361149/ 2014-09-03T07:52:00+00:00 https://www.pharmaceutical-business-review.com/news/lundbeck-launches-northera-to-treat-neurogenic-orthostatic-hypotension-in-us-030914-4361142/ 2014-09-03T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/knight-therapeutics-acquires-orphan-canada-030914-4361317/ 2014-09-03T07:58:00+00:00 https://www.pharmaceutical-business-review.com/news/chimerix-and-barda-continu-partnership-in-development-of-brincidofovir-for-smallpox-030914-4361305/ 2014-09-03T08:26:00+00:00 https://www.pharmaceutical-business-review.com/news/alkermes-completes-patient-enrollment-in-phase-ii-alks-3831-trial-to-treat-schizophrenia-040914-4362625/ 2014-09-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/viiv-healthcares-hiv-drug-triumeq-gets-marketing-authorisation-in-europe-040914-4361514/ 2014-09-03T23:29:00+00:00 https://www.pharmaceutical-business-review.com/news/diplomat-to-distribute-synribo-for-injection-040914-4362180/ 2014-09-04T04:10:00+00:00 https://www.pharmaceutical-business-review.com/news/concordia-to-acquire-us-and-puerto-rican-rights-of-zonegran-from-eisai-040914-4362171/ 2014-09-04T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/cmc-biologics-zymeworks-partner-for-bi-specific-antibody-product-candidate-040914-4362280/ 2014-09-04T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/alimeras-iluvien-secures-swedish-marketing-authorization-to-treat-chronic-dme-040914-4362302/ 2014-09-04T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/halozyme-gets-fast-track-status-for-pegph20-program-in-metastatic-pancreatic-cancer-040914-4362346/ 2014-09-04T07:23:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-to-develop-and-commercialize-infinitys-cancer-drug-duvelisib-040914-4362449/ 2014-09-04T07:23:00+00:00 https://www.pharmaceutical-business-review.com/news/rexahn-secures-notice-of-allowance-from-uspto-for-new-targeted-cancer-drug-delivery-platform-040914-4362633/ 2014-09-04T08:05:00+00:00 https://www.pharmaceutical-business-review.com/news/ppd-acquires-rct-logics-exclusive-license-to-patented-clinical-trial-design-technology-040914-4362638/ 2014-09-04T08:09:00+00:00 https://www.pharmaceutical-business-review.com/news/sunshine-biopharma-negotiates-with-cros-to-begin-master-drug-file-for-adva-27a-anticancer-compound-040914-4362642/ 2014-09-04T08:13:00+00:00 https://www.pharmaceutical-business-review.com/news/delmar-receives-notice-of-allowance-for-second-us-patent-for-val-083-040914-4362645/ 2014-09-04T08:17:00+00:00 https://www.pharmaceutical-business-review.com/news/cleave-starts-phase-i-trial-of-cb-5083-for-multiple-myeloma-treatment-050914-4365599/ 2014-09-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-seeks-marketing-approval-for-aflibercept-solution-for-injection-in-japan-050914-4362823/ 2014-09-04T23:39:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-removes-partial-clinical-hold-on-oncomeds-phase-i-clinical-trials-of-ipafricept-050914-4363464/ 2014-09-05T04:24:00+00:00 https://www.pharmaceutical-business-review.com/news/sellas-inks-license-deal-with-msk-for-wt1-cancer-vaccine-050914-4363520/ 2014-09-05T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/alitair-secures-us-composition-of-matter-patent-for-benzonatate-polacrilex-050914-4363546/ 2014-09-05T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/advancement-of-ascendias-nano-emulsion-technology-platform-with-its-lead-development-program-asd-002-050914-4363594/ 2014-09-05T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/scra-technology-ventures-reports-phase-ii-clinical-trial-results-050914-4363598/ 2014-09-05T04:58:00+00:00 https://www.pharmaceutical-business-review.com/news/dpt-laboratories-acquires-meda-pharmaceuticals-facilities-in-lakewood-050914-4363601/ 2014-09-05T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/psi-cro-further-strengthens-capabilities-in-infectious-diseases-clinical-trials-050914-4363606/ 2014-09-05T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/university-of-british-columbia-gets-nserc-grant-in-support-of-collaborative-rd-work-with-bioasis-050914-4363610/ 2014-09-05T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/newlink-genetics-gets-fda-approval-to-begin-phase-i-human-trials-of-ebola-vaccine-050914-4363708/ 2014-09-05T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/navidea-inks-deal-with-hainan-to-develop-commercialize-lymphoseek-in-china-050914-4363755/ 2014-09-05T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-mercks-anti-pd-1-therapy-keytruda-050614-4363817/ 2014-09-05T07:01:00+00:00 https://www.pharmaceutical-business-review.com/news/nida-awards-grant-for-clinical-research-of-mn-166-in-opioid-dependence-080914-4365155/ 2014-09-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-ferric-citrate-for-ckd-dialysis-patients-with-hyperphosphatemia-080914-4365193/ 2014-09-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-submits-nda-for-leuplin-to-treat-hormone-dependent-diseases-in-japan-080914-4364370/ 2014-09-07T23:29:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-filing-of-astellas-nda-for-isavuconazole-to-treat-fungal-infections-080914-4365126/ 2014-09-07T23:38:00+00:00 https://www.pharmaceutical-business-review.com/news/wellspring-acquires-motion-sickness-drug-bonine-from-prestige-brands-080914-4364941/ 2014-09-08T04:17:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-actavis-nda-filing-for-ceftazidime-avibactam-080914-4364956/ 2014-09-08T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/soligenix-expands-pipeline-with-acquisition-of-phase-iii-ready-oncology-clinical-program-080914-4364972/ 2014-09-08T04:24:00+00:00 https://www.pharmaceutical-business-review.com/news/melinta-reports-pk-profile-of-single-oral-dose-delafloxacin-to-support-us-phase-iii-gonorrhea-program-080914-4364987/ 2014-09-08T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/meiji-takeda-enter-into-co-promotion-agreement-for-insomnia-drug-rozerem-in-japan-080914-4365019/ 2014-09-08T04:50:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-generic-boniva-injection-080914-4365036/ 2014-09-08T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/breckenridge-announces-paragraph-iv-anda-litigation-with-novartis-for-generic-version-of-zortress-080914-4365052/ 2014-09-08T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/act-gets-us-patent-for-dendritic-cells-manufacturing-from-renewable-stem-cell-sources-080914-4365065/ 2014-09-08T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithklines-phase-iiibiv-combination-trial-for-hypertension-meets-primary-endpoint-090914-4365558/ 2014-09-08T23:41:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-plans-new-medical-centre-in-sierra-leone-to-treat-ebola-virus-victims-090914-4366036/ 2014-09-09T03:18:00+00:00 https://www.pharmaceutical-business-review.com/news/university-of-toronto-janssen-to-research-new-treatments-for-major-brain-disorders-090914-4365861/ 2014-09-09T03:23:00+00:00 https://www.pharmaceutical-business-review.com/news/molecular-templates-ind-application-for-mt-3724-gets-fda-clearance-090914-4366064/ 2014-09-09T03:25:00+00:00 https://www.pharmaceutical-business-review.com/news/par-pharmaceutical-resumes-shipment-of-generic-precedex-injection-090914-4366413/ 2014-09-09T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmatech-enters-into-research-collaboration-with-weill-cornell-medical-college-090914-4366427/ 2014-09-09T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmathene-nanotherapeutics-to-advance-biodefense-programs-090914-4366464/ 2014-09-09T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/momenta-exercises-option-to-buy-new-antibody-program-from-anaptysbio-090914-4366473/ 2014-09-09T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/critical-outcome-technologies-ut-md-anderson-sign-letter-of-ontent-for-phase-1-development-of-coti-2-090914-4366484/ 2014-09-09T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/roches-roactemra-gets-european-approval-to-treat-early-rheumatoid-arthritis-090914-4366599/ 2014-09-09T06:47:00+00:00 https://www.pharmaceutical-business-review.com/news/emergent-biosolutions-to-develop-dry-formulation-of-anthrax-vaccine-nuthrax-090914-4366643/ 2014-09-09T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-japan-astellas-to-terminate-distribution-and-co-promotion-of-caduet-combination-tablets-090914-4366675/ 2014-09-09T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/soligenix-announces-issuance-of-us-patent-for-thermovax-technology-090914-4368344/ 2014-09-09T22:28:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/c3-jian-completes-phase-2-clinical-trial-of-anti-cavity-drug-100914-4368355/ 2014-09-09T22:29:00+00:00 https://www.pharmaceutical-business-review.com/news/galena-doses-first-patient-in-phase-ii-trial-of-gale-401-to-treat-mpn-related-thrombocytosis-100914-4367233/ 2014-09-09T23:41:00+00:00 https://www.pharmaceutical-business-review.com/news/ebola-outbreak-serious-threat-to-liberias-national-existence-says-defence-minister-100914-4367390/ 2014-09-10T01:14:00+00:00 https://www.pharmaceutical-business-review.com/news/alternaturals-announces-exclusive-new-products-and-marketing-strategy-100914-4367680/ 2014-09-10T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/sri-international-nobelpharma-ink-deal-to-develop-endometriosis-drug-100914-4368072/ 2014-09-10T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/oncore-neurovive-partner-for-second-generation-cyclophilin-inhibitors-to-treat-hbv-100914-4368183/ 2014-09-10T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/evoke-pharma-completes-patient-enrollment-in-ecg-trial-for-evk-001-100914-4368118/ 2014-09-10T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/lees-pharmaceutical-ink-deal-with-abiogen-to-market-cholecalciferol-100914-4368345/ 2014-09-10T07:11:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-three-additional-patents-to-strengthen-mersanas-adc-technologies-100914-4368288/ 2014-09-10T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/sutro-biopharma-to-collaborate-with-university-of-california-as-part-of-recombinant-antibody-network-090914-4368326/ 2014-09-10T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/relypsa-announces-commercial-manufacturing-agreement-with-patheon-090914-4368336/ 2014-09-10T07:27:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-and-boehringers-insulin-glargine-product-gets-european-marketing-approval-110914-4368798/ 2014-09-10T23:30:00+00:00 https://www.pharmaceutical-business-review.com/news/viacyte-gets-166m-grant-from-cirm-to-develop-vc-01-diabetes-therapy-candidate-110914-4369286/ 2014-09-11T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-ireland-to-buy-us-rights-of-arixtra-injection-from-aspen-110914-4369301/ 2014-09-11T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-joins-with-research-councils-in-uk-and-south-africa-to-tackle-non-communicable-diseases-in-africa-110914-4369759/ 2014-09-11T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-enters-into-antibody-drug-conjugate-deal-with-genmab-110914-4369336/ 2014-09-11T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-canada-launches-escitalopram-generic-version-of-cipralex-110914-4369780/ 2014-09-11T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/cantrell-improves-compounding-safety-with-closed-vial-filling-system-from-aseptic-technologies-110914-4369807/ 2014-09-11T04:52:00+00:00 https://www.pharmaceutical-business-review.com/news/new-medicines-in-development-give-hope-to-patients-with-hivaids-110914-4369820/ 2014-09-11T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/emd-serono-accelerated-cure-project-to-optimize-treatment-and-understand-progression-of-multiple-sclerosis-110914-4369835/ 2014-09-11T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/oculus-launches-otc-advanced-scar-management-hydrogel-in-us-110914-4370168/ 2014-09-11T08:18:00+00:00 https://www.pharmaceutical-business-review.com/news/g1-therapeutics-begins-phase-i-clinical-trial-of-g1t28-1-for-several-oncology-indications-110914-4370232/ 2014-09-11T08:18:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-astellas-and-medivations-expanded-use-of-prostate-cancer-drug-xtandi-110914-4369196/ 2014-09-11T13:47:00+00:00 https://www.pharmaceutical-business-review.com/news/asterias-cancer-research-uk-ink-deal-for-new-lung-cancer-vaccine-120914-4370472/ 2014-09-11T23:44:00+00:00 https://www.pharmaceutical-business-review.com/news/genocea-begins-phase-iia-trial-of-gen-004-to-treat-pneumococcus-4370685/ 2014-09-12T03:37:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-for-vt-1129-to-treat-cryptococcal-meningitis-120914-4370841/ 2014-09-12T03:38:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-reports-positive-phase-iii-trial-results-of-humira-in-hidradenitis-suppurativa-patients-120914-4370912/ 2014-09-12T03:38:00+00:00 https://www.pharmaceutical-business-review.com/news/oxygen-biotherapeutics-halts-phase-iib-traumatic-brain-injury-trial-of-oxycyte-120914-4370862/ 2014-09-12T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/lakewood-amedex-gets-notice-of-allowance-from-uspto-for-new-patent-covering-nanorna-gene-silencing-technology-120914-4371216/ 2014-09-12T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/grafix-randomized-controlled-clinical-trial-recognized-as-high-quality-dfu-trial-in-recent-wounds-supplement-120914-4371249/ 2014-09-12T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/marina-biotech-announces-continued-worldwide-expansion-of-delivery-technology-intellectual-property-estate-120914-4371267/ 2014-09-12T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/prosonix-confirms-potential-of-mcp-technology-to-develop-new-fdc-therapies-for-respiratory-diseases-120914-4371280/ 2014-09-12T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/neostem-enters-into-license-deal-with-rockefeller-university-to-expand-cancer-immunotherapy-120914-4371296/ 2014-09-12T05:13:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-takeda-and-orexigens-contrave-for-chronic-weight-management-120914-4371451/ 2014-09-12T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/cellerant-gets-475m-contract-to-support-development-of-clt-008-120914-4371671/ 2014-09-12T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-baxter-and-halozymes-hyqvia-to-treat-primary-immunodeficiency-150914-4372025/ 2014-09-15T01:34:00+00:00 https://www.pharmaceutical-business-review.com/news/medipost-gets-fda-approval-for-phase-iii-trial-of-pneumostem-to-treat-bpd-150914-4372333/ 2014-09-15T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/synthetic-biologics-gets-fda-orphan-drug-status-for-syn-005-to-treat-whooping-cough-150914-4372371/ 2014-09-15T06:02:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-adds-hdp-treatment-aln-agt-to-strengthen-pipeline-150914-4372411/ 2014-09-15T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/huya-bioscience-tipr-form-jv-for-new-medical-technologies-in-global-markets-150914-4372462/ 2014-09-15T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-serono-stops-clinical-trials-of-lung-cancer-vaccine-150914-4373021/ 2014-09-15T06:46:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-committee-recommends-approval-of-natpara-to-treat-hypoparathyroidism-150914-4373158/ 2014-09-15T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-receives-positive-vote-from-fda-advisory-committee-for-approval-of-saxenda-150914-4373172/ 2014-09-15T07:04:00+00:00 https://www.pharmaceutical-business-review.com/news/alexion-report-new-data-from-two-open-label-phase-ii-studies-of-asfotase-alfa-in-pediatric-patients-150914-4373185/ 2014-09-15T07:09:00+00:00 https://www.pharmaceutical-business-review.com/news/chromadex-and-healthy-directions-enter-into-niagen-supply-agreement-150914-4373196/ 2014-09-15T07:13:00+00:00 https://www.pharmaceutical-business-review.com/news/global-medical-and-nutrition-experts-assemble-to-address-challenge-of-achieving-optimal-nutrition-150914-4373218/ 2014-09-15T07:20:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-enters-two-joint-research-agreements-to-develop-new-antimalarial-medicines-160914-4377298/ 2014-09-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-and-orion-initiate-phase-iii-trial-of-novel-prostate-cancer-agent-odm-201-160914-4377308/ 2014-09-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-eli-lilly-present-results-from-phase-iii-study-of-empagliflozinlinagliptin-combination-tablet-for-type-2-diabetes-160914-4377313/ 2014-09-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-commences-phase-iii-clinical-trials-for-its-generic-version-of-advair-diskus-and-insulin-analog-to-lantus-160914-4377315/ 2014-09-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-exercises-option-for-five-primes-skeletal-muscle-disease-target-160914-4373533/ 2014-09-15T23:55:00+00:00 https://www.pharmaceutical-business-review.com/news/cognizant-agrees-to-buy-trizetto-for-27bn-160914-4374006/ 2014-09-16T04:06:00+00:00 https://www.pharmaceutical-business-review.com/news/us-beefs-up-efforts-to-fight-ebola-160914-4374069/ 2014-09-16T04:08:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-lilly-to-develop-and-commercialize-bace-inhibitor-to-treat-alzheimers-disease-160914-4373942/ 2014-09-16T04:12:00+00:00 https://www.pharmaceutical-business-review.com/news/hyd-pharma-successfully-completes-research-phase-of-new-cancer-drug-160914-4374075/ 2014-09-16T06:38:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-releases-phase-iii-study-data-of-oral-treatment-for-osteoporosis-160914-4374424/ 2014-09-16T07:01:00+00:00 https://www.pharmaceutical-business-review.com/news/ptc-therapeutics-expands-global-presence-in-support-of-translarna-launch-in-duchenne-muscular-dystrophy-170914-4377322/ 2014-09-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/glenmarks-trpa1-antagonist-grc-17536-shows-positive-data-in-a-proof-of-concept-study-170914-4377333/ 2014-09-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-presents-first-phase-3-data-in-japanese-patients-for-omarigliptin-170914-4377337/ 2014-09-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sagent-pharmaceuticals-launches-ketorolac-tromethamine-injection-usp-170914-4377343/ 2014-09-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cardiorentis-announces-eur45m-financing-with-healthcare-royalty-partners-170914-4377353/ 2014-09-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/medgenesis-pfizer-partner-on-parkinsons-disease-treatments-170914-4375138/ 2014-09-17T00:00:00+00:00 https://www.pharmaceutical-business-review.com/news/endo-offers-22bn-to-acquire-auxilium-171914-4375488/ 2014-09-17T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-approves-aurobindos-generic-anti-infective-drug-170914-4375494/ 2014-09-17T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-resolves-risk-management-violation-issue-at-montana-facility-in-us-170914-4375668/ 2014-09-17T07:39:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-movantik-tablets-for-opioid-induced-constipation-treatment-170914-4375667/ 2014-09-17T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-commences-phase-iii-clinical-trials-for-lampalizumab-170914-4376109/ 2014-09-17T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/akashi-therapeutics-acquires-global-rights-to-gsmtx-4-compound-170914-4376471/ 2014-09-17T07:51:00+00:00 https://www.pharmaceutical-business-review.com/news/lupin-and-merck-serono-enter-into-strategic-alliance-170914-4376475/ 2014-09-17T07:59:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-reports-positive-phase-iii-trial-results-of-trelagliptin-succinate-to-treat-type-2-diabetes-180914-4378021/ 2014-09-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/soligenix-secured-fda-clearance-of-phase-iii-trial-of-lymphoma-drug-sgx301-180914-4378027/ 2014-09-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sun-pharma-and-merck-sign-exclusive-worldwide-licensing-agreement-for-tildrakizumab-180914-4376712/ 2014-09-17T23:39:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-myokardia-partner-to-develop-new-therapies-for-genetic-heart-disease-180914-4377243/ 2014-09-18T03:48:00+00:00 https://www.pharmaceutical-business-review.com/news/mgb-biopharma-gets-4m-to-advance-new-lead-antibacterial-mgb-bp-3-into-clinical-development-180914-4377561/ 2014-09-18T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/enumeral-gets-phase-ii-sbir-contract-from-nci-to-advance-human-tissue-immuno-oncology-profiling-180914-4377608/ 2014-09-18T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/mjff-enters-into-new-research-collaboration-with-bachmann-strauss-dystonia-and-parkinson-foundation-180914-4377626/ 2014-09-18T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/achaogen-enrolls-first-patient-in-phase-iii-trial-of-plazomicin-to-treat-infections-caused-by-carbapenem-resistant-enterobacteriaceae-180914-4377637/ 2014-09-18T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/prosensa-starts-re-dosing-of-drisapersen-in-north-america-in-patients-with-duchenne-muscular-dystrophy-180914-4377654/ 2014-09-18T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/isis-pharma-gets-4m-milestone-payment-from-achaogen-for-phase-iii-plazomicin-trial-180914-4377958/ 2014-09-18T07:44:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-serono-sutro-biopharma-ink-deal-for-new-antibody-drug-conjugates-180914-4377985/ 2014-09-18T07:47:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-curevac-to-develop-next-generation-lung-cancer-immunotherapy-190914-4378221/ 2014-09-18T23:45:00+00:00 https://www.pharmaceutical-business-review.com/news/navideas-lymphoseek-cancer-drug-gets-fda-orphan-drug-status-190914-4378995/ 2014-09-19T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/axxess-pharma-to-launch-new-all-natural-fat-burning-ready-to-drink-rtd-protein-meal-replacement-within-15-days-190914-4379121/ 2014-09-19T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/bioasis-begins-mps-ii-trial-with-lysosomal-storage-disease-expert-dr-maurizio-scarpa-and-the-brains-for-brain-foundation-190914-4379143/ 2014-09-19T05:10:00+00:00 https://www.pharmaceutical-business-review.com/news/myos-inks-deal-with-hmt-to-conduct-clinical-metabolomic-trial-in-subjects-using-fortetropin-190914-4379165/ 2014-09-19T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/spectrum-out-licenses-rights-for-china-to-casi-pharmaceuticals-for-three-of-its-drugs-190914-4379198/ 2014-09-19T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-plans-to-focus-entirely-on-life-science-businesses-190914-4379216/ 2014-09-19T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/biostar-files-prc-patent-application-for-oleanolic-acid-injection-for-hepatitis-b-and-liver-cancer-190914-4379226/ 2014-09-19T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/biocryst-gets-additional-niaid-funding-to-develop-bcx4430-for-hemorrhagic-virus-diseases-190914-4379095/ 2014-09-19T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/lillys-trulicity-type-2-diabetes-drug-gets-fda-approval-190914-4379283/ 2014-09-19T07:23:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisks-phase-iiib-trial-of-ryzodeg-fails-to-meet-primary-endpoint-190914-4379408/ 2014-09-19T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/innovus-pharma-inks-distribution-deal-with-tramorgan-for-sensum-in-uk-190914-4379496/ 2014-09-19T07:26:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-to-pay-297m-over-bribery-scandal-in-china-190914-4379543/ 2014-09-19T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-reports-positive-results-from-phase-iii-trial-of-exenatide-in-type-2-diabetes-220914-4379740/ 2014-09-21T23:16:00+00:00 https://www.pharmaceutical-business-review.com/news/gileads-cancer-drug-zydelig-gets-european-marketing-approval-220914-4380415/ 2014-09-22T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/packaging-coordinators-completes-acquisition-of-biotec-220914-4380454/ 2014-09-22T04:50:00+00:00 https://www.pharmaceutical-business-review.com/news/fibrogen-reports-one-year-data-of-fg-3019-in-patients-with-idiopathic-pulmonary-fibrosis-220914-4380476/ 2014-09-22T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-reports-data-from-phase-iii-panorama-1-trial-of-lbh589-in-patients-with-multiple-myeloma-220914-4380486/ 2014-09-22T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-acquires-vidara-therapeutics-international-220914-4380598/ 2014-09-22T05:56:00+00:00 https://www.pharmaceutical-business-review.com/news/personalised-treatment-on-horizon-for-rare-genetic-disease-patients-220914-4380621/ 2014-09-22T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-foundation-provides-2m-grant-to-support-last-mile-vaccine-coverage-in-africa-220914-4380639/ 2014-09-22T06:10:00+00:00 https://www.pharmaceutical-business-review.com/news/soligenix-secures-niaid-contract-to-develop-heat-stable-rivax-vaccine-220914-4380663/ 2014-09-22T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/alcobra-completes-all-patient-visits-in-phase-iii-trial-of-mdx-in-adult-adhd-220914-4380774/ 2014-09-22T08:07:00+00:00 https://www.pharmaceutical-business-review.com/news/grifols-introduces-2000-fviii-iu-alphanate-assay-220914-4380744/ 2014-09-22T08:09:00+00:00 https://www.pharmaceutical-business-review.com/news/japan-approves-bayers-eylea-to-treat-myopic-choroidal-neovascularization-230914-4381048/ 2014-09-22T23:39:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-agrees-to-buy-sigma-aldrich-for-17bn-230914-4380857/ 2014-09-23T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/clinical-inks-esouce-platform-selected-to-power-global-cns-study-230914-4381644/ 2014-09-23T02:26:00+00:00 https://www.pharmaceutical-business-review.com/news/access-pharma-announces-exclusive-global-plasma-therapeutics-license-new-management-and-new-corporate-name-230914-4381673/ 2014-09-23T02:37:00+00:00 https://www.pharmaceutical-business-review.com/news/plandai-to-develop-extract-to-enter-lucrative-erectile-dysfunction-market-with-all-natural-substitute-for-viagra-230914-4381675/ 2014-09-23T02:37:00+00:00 https://www.pharmaceutical-business-review.com/news/taurx-therapeutics-achieves-enrolment-target-for-second-phase-iii-clinical-trial-of-lmtx-in-alzheimers-disease-230914-4381687/ 2014-09-23T02:41:00+00:00 https://www.pharmaceutical-business-review.com/news/university-of-california-completes-pterostilbene-study-to-prevent-skin-damage-from-uv-exposure-230914-4381693/ 2014-09-23T02:45:00+00:00 https://www.pharmaceutical-business-review.com/news/novadel-sells-zolpimist-nda-license-and-intellectual-property-to-amherst-pharma-230914-4381539/ 2014-09-23T02:54:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-completes-review-of-minervas-ind-application-for-insomnia-drug-candidate-min-202-230914-4381374/ 2014-09-23T02:56:00+00:00 https://www.pharmaceutical-business-review.com/news/sirona-biochem-begins-anti-aging-preclinical-studies-230914-4381633/ 2014-09-23T03:00:00+00:00 https://www.pharmaceutical-business-review.com/news/anacor-introduces-kerydin-topical-solution-5-in-us-230914-4382327/ 2014-09-23T06:51:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-files-bla-for-investigational-bite-immunotherapy-blinatumomab-to-treat-leukemia-230914-4382283/ 2014-09-23T06:52:00+00:00 https://www.pharmaceutical-business-review.com/news/orimed-to-market-innovus-pharmas-products-in-canada-230914-4382369/ 2014-09-23T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/celgenes-otezla-psoriasis-drug-obtains-fda-approval-240914-4382777/ 2014-09-23T23:37:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-status-to-medimmunes-medi3902-for-prevention-of-p-aeruginosa-240914-4383445/ 2014-09-24T03:29:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-galmeds-request-for-fast-track-status-of-aramchol-240914-4383688/ 2014-09-24T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/amdipharm-mercury-launches-hypertension-drug-nicardipine-in-uk-240914-4383772/ 2014-09-24T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/atara-biotherapeutics-enters-into-immunotherapy-alliance-with-msk-240914-4383820/ 2014-09-24T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/noxxon-gets-fda-orphan-drug-status-for-olaptesed-pegol-to-treat-glioblastoma-240914-4383863/ 2014-09-24T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-to-build-large-campus-in-lawrenceville-us-240914-4384110/ 2014-09-24T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/collegium-announces-issuance-of-us-patent-covering-deterx-technology-platform-240914-4384120/ 2014-09-24T07:48:00+00:00 https://www.pharmaceutical-business-review.com/news/syros-pharmaceuticals-presents-research-on-gene-control-in-acute-myeloid-leukemia-240914-4384130/ 2014-09-24T07:48:00+00:00 https://www.pharmaceutical-business-review.com/news/iceutica-receives-key-patent-for-solumatrix-fine-particle-technology-platform-240914-4384141/ 2014-09-24T07:51:00+00:00 https://www.pharmaceutical-business-review.com/news/navidea-gets-167m-fast-track-nih-sbir-grant-to-evaluate-lymphoseek-in-cervical-cancer-240914-4384078/ 2014-09-24T08:07:00+00:00 https://www.pharmaceutical-business-review.com/news/fibrocell-intrexon-to-file-nda-for-gm-hdf-col7-to-treat-epidermolysis-bullosa-250914-4385497/ 2014-09-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-files-nda-for-fixed-dose-combination-of-edipasvirsofosbuvir-in-japan-250914-4384695/ 2014-09-25T03:59:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-novens-new-dose-for-minivelle-to-prevent-postmenopausal-osteoporosis-250914-4384750/ 2014-09-25T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/inovios-ebola-vaccine-moving-into-human-trial-with-geneone-life-science-250914-4385197/ 2014-09-25T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/cortex-enters-into-agreement-with-the-national-institute-of-drug-abuse-250914-4385208/ 2014-09-25T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/circulomics-gets-phase-i-sbir-to-develop-nanobind-extraction-method-for-ffpe-samples-250914-4385221/ 2014-09-25T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/regulus-gets-notice-of-allowance-from-uspto-related-to-microrna-103107-program-in-metabolic-disorders-250914-4385230/ 2014-09-25T04:52:00+00:00 https://www.pharmaceutical-business-review.com/news/lipocine-reports-positive-top-line-results-from-phase-iii-study-of-lpcn-1021-250914-4385242/ 2014-09-25T04:58:00+00:00 https://www.pharmaceutical-business-review.com/news/rexahns-rx-3117-gets-fda-orphan-drug-status-for-pancreatic-cancer-treatment-250914-4384861/ 2014-09-25T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/brazil-releases-over-10000-dengue-blocking-mosquitoes-250914-4385424/ 2014-09-25T06:16:00+00:00 https://www.pharmaceutical-business-review.com/news/innovus-inks-license-deal-with-sothema-for-zestra-and-zestra-glide-250914-4385564/ 2014-09-25T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-merrimack-collaborate-on-new-cancer-compound-mm-398-250914-4384180/ 2014-09-25T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/immunocellular-caltech-enter-licensing-deal-for-new-antigen-specific-t-cell-technology-250914-4385607/ 2014-09-25T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-confirms-generic-butrans-patent-challenge-260914-4387280/ 2014-09-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmacyclics-and-servier-agree-to-conclude-pan-hdac-inhibitor-collaboration-260914-4387288/ 2014-09-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mabvax-receives-orphan-drug-designation-for-therapeutic-vaccine-to-treat-childhood-cancer-neuroblastoma-290914-4387297/ 2014-09-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-acquires-innopharma-260914-4385982/ 2014-09-25T23:45:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-gets-fda-approval-for-crohns-disease-drug-humira-4386137/ 2014-09-26T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-to-build-new-obesity-research-unit-in-us-260914-4386253/ 2014-09-26T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-to-invest-25m-in-drug-discovery-firm-biomotiv-260914-4386400/ 2014-09-26T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/international-collaboration-to-develop-inhaled-form-of-oxytocin-260914-4386870/ 2014-09-26T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/adaptimmune-secures-104m-in-series-a-financing-260914-4386899/ 2014-09-26T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/medimmune-cancer-research-uk-to-establish-joint-laboratory-for-new-biologic-cancer-medicines-260914-4387221/ 2014-09-26T07:23:00+00:00 https://www.pharmaceutical-business-review.com/news/epirus-livzon-mabpharm-enter-deal-for-five-biosimilar-products-in-china-260914-4387318/ 2014-09-26T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/cormedix-submits-ind-application-for-neutrolin-to-us-fda-260914-4387349/ 2014-09-26T08:06:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-to-acquire-ambit-biosciences-290914-4389026/ 2014-09-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-committee-issues-positive-opinion-for-boehringers-lung-cancer-drug-nintedanib-290914-4387710/ 2014-09-28T23:40:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-panel-recommends-european-approval-of-cancer-drug-lymphoseek-290914-4388556/ 2014-09-29T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-secures-positive-opinion-from-ema-committee-for-harvoni-to-treat-hcv-infection-290914-4388585/ 2014-09-29T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/takedas-nda-for-fomepizole-gets-approval-in-japan-290914-4388617/ 2014-09-29T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/alimeras-iluvien-gets-fda-approval-for-diabetic-macular-edema-treatment-290914-4388647/ 2014-09-29T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/sumitomo-dainippon-sanbio-partner-over-sb623-cell-therapy-for-chronic-stroke-290914-4388836/ 2014-09-29T07:58:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmaengine-merrimack-amend-license-deal-for-nanoliposomal-irinotecan-injection-290914-4388758/ 2014-09-29T07:59:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-announces-multiple-regulatory-milestones-for-opdivo-in-us-and-eu-290914-4389017/ 2014-09-29T09:02:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-reports-phase-3-cou-aa-302-trial-results-of-zytiga-290914-4389036/ 2014-09-29T09:07:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-takeda-report-positive-data-from-phase-3-aethera-clinical-trial-of-adcetris-290914-4389074/ 2014-09-29T09:15:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-reports-early-data-on-investigational-use-of-keytruda-in-patients-with-advanced-bladder-cancer-290914-4389075/ 2014-09-29T09:15:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-reports-positive-results-from-phase-iii-break-3-trial-of-tafinlar-to-treat-melanoma-300914-4389326/ 2014-09-29T23:32:00+00:00 https://www.pharmaceutical-business-review.com/news/ligand-earns-milestone-payment-triggered-by-eu-approval-of-mercks-captisol-enabled-noxafil-300914-4389024/ 2014-09-29T23:59:00+00:00 https://www.pharmaceutical-business-review.com/news/amag-to-buy-lumaras-women-health-business-for-675m-300914-4389521/ 2014-09-30T02:57:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-transfers-preclinical-assets-to-imago-pharmaceuticals-300914-4389595/ 2014-09-30T02:57:00+00:00 https://www.pharmaceutical-business-review.com/news/vitavis-launches-pruvin-to-combat-effects-of-aging-on-metabolism-300914-4389816/ 2014-09-30T03:01:00+00:00 https://www.pharmaceutical-business-review.com/news/kamada-announces-second-extension-of-strategic-agreement-with-baxter-300914-4389901/ 2014-09-30T04:23:00+00:00 https://www.pharmaceutical-business-review.com/news/mymetics-hiv-vaccine-candidate-gets-funding-to-begin-study-at-texas-biomedical-research-institute-300914-4389881/ 2014-09-30T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-reports-positive-phase-iii-data-for-opdivo-in-advanced-melanoma-patients-300914-4389894/ 2014-09-30T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/cannabis-science-signs-drug-development-and-laboratory-services-agreement-with-immunoclin-300914-4389924/ 2014-09-30T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/otsuka-gets-fda-approval-for-dual-chamber-syringe-for-abilify-maintena-to-treat-schizophrenia-300914-4389909/ 2014-09-30T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/macrogenics-takeda-partner-to-develop-four-additional-dart-therapeutics-300914-4390338/ 2014-09-30T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/therapeuticsmd-starts-phase-iii-trial-of-tx-004hr-to-treat-vva-300914-4390537/ 2014-09-30T07:44:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-validates-the-marketing-authorization-for-lung-cancer-drug-nivolumab-300914-4390669/ 2014-09-30T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/regeneron-sanofi-report-positive-phase-ii-trial-results-of-dupilumab-in-cswnp-patients-011014-4392888/ 2014-09-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/dandrit-san-martino-hospital-to-begin-phase-ii-trials-of-colorectal-cancer-vaccine-melcancervac-011014-4392896/ 2014-09-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-invests-100m-to-increase-respimat-production-in-dortmund-011014-4390791/ 2014-09-30T23:42:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/inergetics-launches-surgex-warrior-sports-nutrition-011014-4391603/ 2014-10-01T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/johnson-johnson-to-buy-alios-biopharma-for-175bn-011014-4391646/ 2014-10-01T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/kai-secures-cdc-contract-to-support-annual-influenza-vaccine-serology-testing-011014-4391772/ 2014-10-01T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/kempharm-gets-patent-from-uspto-for-new-prodrug-of-hydromorphone-100114-4391787/ 2014-10-01T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-can-fite-patent-for-cf102-to-treat-liver-regeneration-and-function-after-surgery-011014-4391801/ 2014-10-01T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/cellular-biomedicine-completes-acquisition-of-agreen-biotech-011014-4391824/ 2014-10-01T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/csl-behring-expands-manufacturing-facility-in-kankakee-us-011014-4391834/ 2014-10-01T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-xtandi-to-treat-metastatic-castration-resistant-prostate-cancer-011014-4392051/ 2014-10-01T08:27:00+00:00 https://www.pharmaceutical-business-review.com/news/glialogix-fast-forward-partner-to-support-development-of-new-multiple-sclerosis-treatments-011014-4392074/ 2014-10-01T08:34:00+00:00 https://www.pharmaceutical-business-review.com/news/cdc-confirms-first-ebola-case-in-us-021014-4392125/ 2014-10-01T09:57:00+00:00 https://www.pharmaceutical-business-review.com/news/quest-pharmatech-bioceltran-ink-licence-deal-for-photodynamic-therapy-technology-031014-4393412/ 2014-10-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-closes-acquisition-of-merck-consumer-care-for-142bn-03014-4392920/ 2014-10-02T23:39:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-releases-interim-phase-iii-data-supporting-long-term-efficacy-of-vedolizumab-031014-4393144/ 2014-10-02T23:39:00+00:00 https://www.pharmaceutical-business-review.com/news/nkt-therapeutics-secures-fda-fast-track-status-for-nktt120-031014-4393257/ 2014-10-03T04:22:00+00:00 https://www.pharmaceutical-business-review.com/news/tribute-pharma-acquires-canadian-rights-to-fiorinal-fiorinal-c-visken-and-viskazide-031014-4393407/ 2014-10-03T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/prima-biomed-agrees-to-acquire-immutep-031014-4393403/ 2014-10-03T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/neurocrine-begins-tourette-syndrome-clinical-trial-of-nbi-98854-031014-4393416/ 2014-10-03T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/united-cannabis-announces-venture-with-jamaican-cannabinoid-research-development-company-031014-4393413/ 2014-10-03T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/intrexon-amneal-expand-relationship-with-second-product-collaboration-031014-4393421/ 2014-10-03T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/receptos-begins-dosing-in-phase-ii-rpc4046-trial-to-treat-eosinophilic-esophagitis-061014-4395729/ 2014-10-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-gets-fda-orphan-drug-status-for-actimmune-to-treat-friedreichs-ataxia-061014-4393974/ 2014-10-05T23:32:00+00:00 https://www.pharmaceutical-business-review.com/news/argos-plans-for-new-manufacturing-facility-in-durham-north-carolina-061014-4394739/ 2014-10-06T04:32:00+00:00 https://www.pharmaceutical-business-review.com/news/critical-outcomes-cancer-drug-candidate-coti-gets-sixth-us-patent-and-first-japanese-patent-100614-4394752/ 2014-10-06T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/histogenics-intrexon-enter-exclusive-channel-collaboration-for-cartilage-repair-therapies-061014-4394760/ 2014-10-06T04:39:00+00:00 https://www.pharmaceutical-business-review.com/news/rockwell-inks-deal-with-baxter-healthcare-to-commercialize-hemodialysis-concentrates-061014-4394775/ 2014-10-06T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/parexel-acquires-uk-rtsm-services-provider-clinintel-061014-4394798/ 2014-10-06T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/china-oncology-to-develop-and-commercialize-sorrentos-anti-pd-l1-antibody-061014-4394838/ 2014-10-06T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/sagent-recalls-three-lots-of-ketorolac-tromethamine-injection-usp-30mgml-061014-4394990/ 2014-10-06T07:11:00+00:00 https://www.pharmaceutical-business-review.com/news/halozyme-gets-fda-orphan-drug-status-for-pegph20-to-treat-pancreatic-cancer-100614-4395042/ 2014-10-06T07:11:00+00:00 https://www.pharmaceutical-business-review.com/news/norgine-enrolls-first-patient-in-ner1006-phase-iii-noct-trial-061014-4394694/ 2014-10-06T10:10:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-eylea-injection-for-macular-edema-following-retinal-vein-occlusion-071014-4396893/ 2014-10-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-bms-partner-to-evaluate-new-lung-cancer-therapies-071014-4395454/ 2014-10-06T23:23:00+00:00 https://www.pharmaceutical-business-review.com/news/eleven-biotherapeutics-report-top-line-results-from-phase-ii-trial-of-ebi-005-071014-4396125/ 2014-10-07T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/brainstorm-reports-last-patient-visit-in-phase-iia-als-trial-071014-4396135/ 2014-10-07T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/md-anderson-bms-enter-research-collaboration-in-immuno-oncology-focused-on-leukemia-and-hematologic-malignancies-071014-4396150/ 2014-10-07T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/chimerix-announces-emergency-ind-applications-for-brincidofovir-authorized-by-fda-to-treat-ebola-071014-4396172/ 2014-10-07T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/savant-hwp-begins-human-safety-trial-of-anti-addiction-therapy-18-mc-071014-4396339/ 2014-10-07T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/salix-cosmo-technologies-agree-to-terminate-merger-agreement-071014-4395133/ 2014-10-07T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/ariad-and-bellicum-announce-revised-license-agreement-for-ariads-cell-signaling-technology-071014-4396180/ 2014-10-07T04:39:00+00:00 https://www.pharmaceutical-business-review.com/news/cell-cure-files-ind-application-with-fda-for-opregen-to-treat-dry-amd-071014-4396856/ 2014-10-07T08:06:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-abbvies-humira-for-extension-of-polyarticular-jia-indication-071014-4396812/ 2014-10-07T08:09:00+00:00 https://www.pharmaceutical-business-review.com/news/gsks-stiefel-begins-phase-iii-trial-of-subcutaneous-ofatumumab-to-treat-pemphigus-vulgaris-081014-4397137/ 2014-10-07T23:37:00+00:00 https://www.pharmaceutical-business-review.com/news/game-plan-holdings-announces-partnership-with-achieve-nutrition-systems-081014-4397728/ 2014-10-08T04:26:00+00:00 https://www.pharmaceutical-business-review.com/news/second-genome-mayo-clinic-to-develop-microbiome-therapeutics-in-multiple-diseases-081014-4397755/ 2014-10-08T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/cadca-chpa-team-up-to-fight-teen-abuse-of-otc-cough-medicines-081014-4397715/ 2014-10-08T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/marys-medicinals-secures-license-to-401-cbdthc-cannabis-strain-from-green-natural-solutions-081014-4397720/ 2014-10-08T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-warns-consumers-about-some-otc-medicines-over-possible-impair-driving-081014-4398053/ 2014-10-08T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/discoverybiomed-awarded-dual-sbir-awards-for-pkd-drug-discovery-and-validation-081014-4397744/ 2014-10-08T04:39:00+00:00 https://www.pharmaceutical-business-review.com/news/otc-pain-medications-are-more-effective-for-acute-pain-than-prescribed-painkillers-national-safety-council-081014-4397736/ 2014-10-08T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/dnatrixs-dnx-2401-gets-fda-orphan-drug-status-to-treat-malignant-glioma-081014-4398245/ 2014-10-08T06:48:00+00:00 https://www.pharmaceutical-business-review.com/news/brainstorms-nurown-obtains-fda-fast-track-status-for-amyotrophic-lateral-sclerosis-081014-4398333/ 2014-10-08T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/bio-path-completes-cohort-six-of-liposomal-grb-2-phase-i-trial-for-blood-cancers-081014-4398393/ 2014-10-08T07:04:00+00:00 https://www.pharmaceutical-business-review.com/news/pinnacle-begins-phase-iii-bile-duct-cancer-trial-of-photofrin-081014-4398486/ 2014-10-08T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/emd-serono-icr-wellcome-trust-collaborate-to-develop-anti-cancer-drugs-081014-4398524/ 2014-10-08T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-reports-positive-phase-iii-trial-results-of-abp-501-in-plaque-psoriasis-patients-091014-4398851/ 2014-10-08T23:41:00+00:00 https://www.pharmaceutical-business-review.com/news/dilafor-opocrin-sign-supply-and-partnership-deal-for-tafoxiparin-091014-4399338/ 2014-10-09T03:50:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-lucentis-obtains-health-canada-approval-for-visual-impairment-due-to-cnv-091014-4399427/ 2014-10-09T03:52:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-announces-initiation-of-nda-and-positive-results-from-second-human-abuse-liability-study-for-cep-33237-091014-4399235/ 2014-10-09T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/aphios-granted-us-patent-for-nanotechnology-formulation-of-poorly-soluble-drugs-091014-4399231/ 2014-10-09T04:14:00+00:00 https://www.pharmaceutical-business-review.com/news/blaze-bioscience-gets-sbir-phase-ii-funding-for-clinical-trial-of-tumor-paint-blz-100-in-sarcoma-091014-4399245/ 2014-10-09T04:17:00+00:00 https://www.pharmaceutical-business-review.com/news/aciex-announces-issuance-of-separate-us-patents-covering-two-leading-product-candidates-091014-4399226/ 2014-10-09T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/neos-therapeutics-gets-key-patent-covering-extended-release-oral-disintegrating-tablet-xr-odt-platform-technology-091014-4399241/ 2014-10-09T04:23:00+00:00 https://www.pharmaceutical-business-review.com/news/regen-files-ind-application-for-dcellvax-with-fda-to-treat-breast-cancer-091014-4399878/ 2014-10-09T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/salixs-ulcerative-colitis-treatment-uceris-gets-fda-approval-091014-4399936/ 2014-10-09T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-makes-striverdi-respimat-inhalation-spray-5-g-available-in-us-pharmacies-091014-4399998/ 2014-10-09T07:28:00+00:00 https://www.pharmaceutical-business-review.com/news/us-investigates-dr-reddys-and-sun-pharma-over-generic-drugs-price-increases-101014-4400778/ 2014-10-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-to-acquire-25-stake-in-aspen-japan-101014-4400312/ 2014-10-09T23:40:00+00:00 https://www.pharmaceutical-business-review.com/news/cipla-medpro-teva-pharmaceuticals-partner-to-market-products-in-south-africa-101014-4400821/ 2014-10-10T03:53:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-velcade-for-untreated-mantle-cell-lymphoma-101014-4400791/ 2014-10-10T03:54:00+00:00 https://www.pharmaceutical-business-review.com/news/nicox-selects-optimed-as-distributor-in-australia-and-new-zealand-101014-4400808/ 2014-10-10T03:57:00+00:00 https://www.pharmaceutical-business-review.com/news/ebola-crisis-may-result-in-billions-of-economic-loss-work-bank-101014-4400434/ 2014-10-10T04:01:00+00:00 https://www.pharmaceutical-business-review.com/news/brkert-and-business-review-free-webinar-series-offers-specialized-content-for-pharmahealthcarepackagingfood-and-beverage-industry-professionals-4401222/ 2014-10-10T06:47:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/pharmaceutical-firms-to-use-uc-san-diego-led-resource-to-share-data-for-drug-design-101014-4400854/ 2014-10-10T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/hemoshear-completes-initial-development-phase-of-new-cancer-drug-discovery-platform-101014-4400889/ 2014-10-10T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/drug-infused-nanoparticle-is-right-for-sore-eyes-101014-4401132/ 2014-10-10T07:21:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/beijing-sihuan-pharmaceutical-to-collaborate-with-amms-for-anti-ebola-drug-jk-05-101014-4401198/ 2014-10-10T07:28:00+00:00 https://www.pharmaceutical-business-review.com/news/endo-international-to-buy-auxilium-pharmaceuticals-for-26bn-101014-4401321/ 2014-10-10T07:31:00+00:00 https://www.pharmaceutical-business-review.com/news/isis-earns-18m-milestone-payment-from-gsk-for-advancing-isis-ttr-101014-4401501/ 2014-10-10T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/marylands-cvd-starts-first-clinical-trial-of-ebola-vaccine-in-west-africa-101014-4401617/ 2014-10-10T08:35:00+00:00 https://www.pharmaceutical-business-review.com/news/gileads-harvoni-gets-fda-approval-for-genotype-1-chronic-hepatitis-c-treatment-131014-4401876/ 2014-10-13T00:37:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-india-faces-49m-penalty-from-nppa-for-over-pricing-voveran-131014-4402516/ 2014-10-13T04:05:00+00:00 https://www.pharmaceutical-business-review.com/news/puramed-nears-completion-of-hemp-based-otc-medication-to-treat-epilepsy-symptoms-131014-4402695/ 2014-10-13T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/caldolor-reports-favorable-inflammatory-response-results-in-laparoscopic-cholecystectomy-surgery-patients-131014-4402775/ 2014-10-13T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-annoiunces-positive-data-from-phase-iii-studies-of-ain457-in-clearing-skin-of-psoriasis-patients-131014-4402788/ 2014-10-13T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/prosensa-begins-nda-submission-to-fda-for-dmd-drug-drisapersen-131014-4402753/ 2014-10-13T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmaceutical-organizations-using-new-technologies-for-successful-oncology-product-launches-131014-4402802/ 2014-10-13T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-agrees-to-buy-tower-holdings-and-lineage-therapeutics-131014-4402818/ 2014-10-13T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-renews-research-contract-with-symphony-health-solutions-for-outpatient-prescription-and-drug-utilization-data-131014-4402836/ 2014-10-13T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-approval-for-akynzeo-to-treat-chemotherapy-induced-nausea-vomiting-131014-4403003/ 2014-10-13T08:20:00+00:00 https://www.pharmaceutical-business-review.com/news/pfenex-partners-with-path-to-improve-vaccine-production-131014-4402938/ 2014-10-13T08:21:00+00:00 https://www.pharmaceutical-business-review.com/news/hikma-to-distribute-eisais-epilepsy-treatment-fycompa-in-middle-east-131014-4403198/ 2014-10-13T08:23:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-to-pfizers-breast-cancer-drug-palbociclib-141014-4403408/ 2014-10-13T23:39:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-announces-late-breaking-results-from-phase-iii-trial-of-humira-in-hidradenitis-suppurativa-patients-141014-4403973/ 2014-10-14T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/concert-reports-positive-data-from-multiple-dose-phase-1-clinical-trial-of-ctp-354-to-treat-spasticity-141014-4403935/ 2014-10-14T04:32:00+00:00 https://www.pharmaceutical-business-review.com/news/cytrx-begins-operations-at-new-discovery-laboratory-in-germany-141014-4404261/ 2014-10-14T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/dynavax-begins-phase-iii-trial-of-lymphoma-treatment-tlr-9-141014-4404331/ 2014-10-14T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/nuvilex-seeks-fda-orphan-drug-designation-for-cell-in-a-box-pancreatic-cancer-treatment-141014-4404439/ 2014-10-14T06:20:00+00:00 https://www.pharmaceutical-business-review.com/news/tobira-starts-dosing-in-phase-iib-trial-of-cenicriviroc-in-non-alcoholic-steatohepatitis-141014-4404457/ 2014-10-14T06:31:00+00:00 https://www.pharmaceutical-business-review.com/news/veristat-molecular-templates-enter-into-preferred-provider-agreement-for-refractory-non-hodgkins-b-cell-lymphoma-trial-141014-4403952/ 2014-10-14T06:39:00+00:00 https://www.pharmaceutical-business-review.com/news/rich-pharmaceuticals-to-buy-hodgkins-lymphoma-treatment-rights-141014-4403926/ 2014-10-14T06:45:00+00:00 https://www.pharmaceutical-business-review.com/news/orexo-submits-application-to-fda-for-expanded-label-of-zubsolv-141014-4403943/ 2014-10-14T06:47:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-pharmacyclics-and-janssen-collaborate-for-new-non-hodgkin-lymphoma-drug-141014-4404521/ 2014-10-14T07:03:00+00:00 https://www.pharmaceutical-business-review.com/news/sellas-selects-ppd-as-strategic-cro-partner-to-advance-zolpidem-and-wt1-cancer-vaccine-151014-4405475/ 2014-10-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/inc-research-to-perform-fda-due-diligence-audit-of-regulatory-documents-for-provectus-151014-4405511/ 2014-10-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/viiv-healthcare-secures-canadian-approval-for-triumeq-to-treat-hiv-1-151014-4406359/ 2014-10-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/vaxarts-tablet-vaccine-for-h1n1-influenza-generates-protective-immunity-equivalent-to-injectable-in-phase-i-clinical-study-151014-4405466/ 2014-10-14T22:28:00+00:00 https://www.pharmaceutical-business-review.com/news/new-ebola-cases-may-reach-10000-per-week-by-year-end-who-151014-4405072/ 2014-10-15T00:31:00+00:00 https://www.pharmaceutical-business-review.com/news/missionpoint-health-partners-and-second-harvest-food-bank-of-middle-tennessee-create-partnership-151014-4405485/ 2014-10-15T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/macular-health-announces-release-of-macustrip-151014-4405503/ 2014-10-15T04:32:00+00:00 https://www.pharmaceutical-business-review.com/news/encore-consumer-capital-announces-sale-of-isopure-to-glanbia-151014-4405493/ 2014-10-15T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/axxess-pharma-launches-new-tapout-turbo-blend-protein-powder-151014-4405953/ 2014-10-15T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/breckenridge-launches-mefenamic-acid-250mg-capsules-151014-4406014/ 2014-10-15T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-designation-for-eisais-lenvatinib-to-treat-advanced-thyroid-cancer-151014-4406220/ 2014-10-15T06:39:00+00:00 https://www.pharmaceutical-business-review.com/news/sucampo-extends-license-collaboration-agreement-with-takeda-for-amitiza-151014-4406329/ 2014-10-15T07:05:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-gets-fda-approval-for-esbriet-to-treat-idiopathic-pulmonary-fibrosis-161014-4407975/ 2014-10-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/actogenix-reports-positive-results-from-phase-i-trial-of-ag014-to-treat-inflammatory-bowel-disease-161014-4408010/ 2014-10-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/infinity-reports-topline-data-from-phase-2a-exploratory-study-of-duvelisib-in-asthma-patients-161014-4408855/ 2014-10-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-boehringer-ofev-to-treat-idiopathic-pulmonary-fibrosis-161014-4406585/ 2014-10-15T23:26:00+00:00 https://www.pharmaceutical-business-review.com/news/portal-instruments-completes-landmark-11m-series-a-financing-for-new-drug-delivery-platform-161014-4407143/ 2014-10-16T04:58:00+00:00 https://www.pharmaceutical-business-review.com/news/neurosigma-us-veterans-administration-va-enter-into-cooperative-research-and-development-agreement-161014-4407162/ 2014-10-16T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/mariel-therapeutics-announces-issuance-of-two-us-patents-for-use-bmp-7-in-oa-and-ckd-161014-4407133/ 2014-10-16T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/invivo-therapeutics-announces-first-subject-enrolled-in-pilot-spinal-cord-injury-trial-161014-4407150/ 2014-10-16T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/orgenesis-receives-patent-for-potential-cure-for-type-1-diabetes-161014-4407168/ 2014-10-16T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/prima-announces-immuteps-imp321-patent-application-receives-australian-notice-of-allowance-161014-4407186/ 2014-10-16T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/selecta-jdrf-and-sanofi-to-develop-svp-immunotherapy-for-type-1-diabetes-161014-4407831/ 2014-10-16T06:49:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-acquires-lanthios-lanthipeptide-technology-161014-4407869/ 2014-10-16T06:49:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-navideas-lymphoseek-for-lymphatic-mapping-in-solid-tumors-161014-4407898/ 2014-10-16T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-cambridge-university-collaborate-to-research-on-neurodegenerative-diseases-171014-4408336/ 2014-10-17T00:05:00+00:00 https://www.pharmaceutical-business-review.com/news/ranbaxy-agrees-to-pay-3975m-to-settle-texas-medicaid-litigation-171014-4408587/ 2014-10-17T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/noven-files-patent-infringement-lawsuit-against-actavis-171014-4408877/ 2014-10-17T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/ampio-reports-results-of-multiple-intra-articular-injections-mi-study-of-ampion-in-patients-with-osteoarthritis-of-the-knee-171014-4408883/ 2014-10-17T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/bone-biologics-completes-merger-with-afh-acquisition-x-171014-4408891/ 2014-10-17T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/batu-biologics-gets-license-from-california-university-for-cancer-drug-171014-4408867/ 2014-10-17T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/nuvilex-gets-worldwide-license-for-insulin-producing-cells-from-university-of-technology-for-use-in-developing-diabetes-treatment-171014-4408903/ 2014-10-17T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/immune-design-sanofi-pasteur-to-develop-herpes-simplex-virus-therapy-171014-4409249/ 2014-10-17T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/aduro-expands-deal-with-janssen-to-develop-product-candidates-for-lung-cancer-171014-4409458/ 2014-10-17T07:38:00+00:00 https://www.pharmaceutical-business-review.com/news/octreopharms-ops202-receives-fda-orphan-drug-status-for-neuroendocrine-tumors-171014-4409436/ 2014-10-17T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-seeks-fda-approval-to-market-methylphenidate-hydrochloride-5mgml-171014-4409392/ 2014-10-17T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-issues-notice-of-compliance-for-gilead-hepatitis-c-drug-harvoni-171014-4409540/ 2014-10-17T07:47:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-abuse-deterrent-labeling-for-pfizers-embeda-201014-4410892/ 2014-10-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/theravance-reports-positive-results-from-lung-function-trial-of-anoro-ellipta-201014-4411159/ 2014-10-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/epizyme-reports-positive-pre-clinical-phase-iii-trial-results-of-epz-in-synovial-sarcoma-201014-4411174/ 2014-10-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-grants-orphan-drug-status-for-immunomedics-isactuzumab-govitecan-for-pancreatic-cancer-201014-4411177/ 2014-10-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmacyclics-imbruvica-gets-european-approval-to-treat-two-blood-cancers-201014-4409826/ 2014-10-19T23:58:00+00:00 https://www.pharmaceutical-business-review.com/news/dksh-to-offer-market-expansion-services-for-roches-products-across-asia-201014-4410572/ 2014-10-20T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-pharma-acquires-us-rights-to-pennsaid-2-from-nuvo-research-201014-4410668/ 2014-10-20T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/china-biologic-gets-approval-to-manufacture-human-prothrombin-complex-concentrate-at-shandong-taibang-facility-201014-4410168/ 2014-10-20T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-files-lawsuit-against-sanofi-and-regeneron-for-patent-infringement-201014-4410163/ 2014-10-20T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-update-on-current-development-status-of-the-gsknih-ebola-vaccine-candidate-201014-4410172/ 2014-10-20T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/eylea-injection-shows-better-gains-in-visual-acuity-than-both-bevacizumab-and-ranibizumab-in-nih-sponsored-dme-study-201014-4410179/ 2014-10-20T05:14:00+00:00 https://www.pharmaceutical-business-review.com/news/amicus-therapeutics-reports-positive-phase-iii-data-from-fabry-monotherapy-study-011-201014-4410182/ 2014-10-20T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/genervon-reports-phase-iia-trial-results-of-gm6-drug-in-als-and-pd-201014-4411020/ 2014-10-20T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/medimmunes-phase-i-ox40-agonist-trial-uses-agonoxs-ox40-platform-211014-4411475/ 2014-10-21T00:04:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-and-orexigen-launch-weight-management-drug-contrave-in-us-211014-4411395/ 2014-10-21T00:06:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-merck-and-sanofi-pasteurs-bla-for-pediatric-hexavalent-vaccine-211014-4411363/ 2014-10-21T00:08:00+00:00 https://www.pharmaceutical-business-review.com/news/apricus-expands-development-pipeline-with-in-licensing-of-us-rights-for-fispemifene-211014-4412073/ 2014-10-21T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/cerus-submits-compassionate-use-ide-supplement-for-intercept-blood-system-treatment-of-ebola-convalescent-plasma-211014-4412100/ 2014-10-21T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/cannabics-pharmaceuticals-receives-cannabinoid-rd-lab-certification-in-israel-4412088/ 2014-10-21T04:22:00+00:00 https://www.pharmaceutical-business-review.com/news/revalesios-rns60-shows-promise-in-treating-alzheimers-disease-and-other-dementias-211014-4412108/ 2014-10-21T04:24:00+00:00 https://www.pharmaceutical-business-review.com/news/enanta-pharmaceuticals-provides-update-on-its-collaboration-agreement-with-abbvie-211014-4412115/ 2014-10-21T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-introduces-hyqvia-in-us-to-treat-primary-immunodeficiency-211014-4411981/ 2014-10-21T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/matinas-submits-ind-for-mat9001-to-treat-severe-hypertriglyceridemia-211014-4412485/ 2014-10-21T06:36:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-plaque-psoriasis-drug-candidate-ain457-gets-fda-committee-recommendation-211014-4412636/ 2014-10-21T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/immunotech-completes-negotiations-with-uldic-to-market-potential-ebola-treatment-in-africa-221014-4413275/ 2014-10-22T00:01:00+00:00 https://www.pharmaceutical-business-review.com/news/newlink-genentech-ink-licensing-deal-for-development-of-nlg919-221014-4412810/ 2014-10-22T01:23:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-to-review-eisais-snda-for-antiepileptic-drug-perampanel-to-treat-pgtc-seizures-221014-4412764/ 2014-10-22T01:25:00+00:00 https://www.pharmaceutical-business-review.com/news/synageva-begins-rolling-submission-of-bla-to-fda-for-sebelipase-alfa-to-treat-lal-deficiency-221014-4412993/ 2014-10-22T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-auxiliums-xiaflex-to-treat-dupuytrens-contracture-221014-4412576/ 2014-10-22T01:27:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-more-manufacturing-facilities-for-halozymes-hylenex-recombinant-production-221014-4412665/ 2014-10-22T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/phosplatin-starts-dosing-in-phase-i-trial-of-pt-112-for-solid-tumors-221014-4412965/ 2014-10-22T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/therapix-biosciences-signs-non-binding-agreement-to-acquire-dekel-pharmaceuticals-221014-4413668/ 2014-10-22T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/mabvax-therapeutics-nominates-humab-5b1-as-lead-clinical-development-candidate-221014-4413685/ 2014-10-22T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/plandai-biotechnologys-technology-could-prove-potent-in-battling-alzheimers-disease-221014-4413679/ 2014-10-22T04:43:00+00:00 https://www.pharmaceutical-business-review.com/news/chpa-statement-on-pediatrics-study-reporting-medication-errors-in-children-221014-4413683/ 2014-10-22T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/wcct-global-starts-clinical-trial-patient-rescue-program-with-pay-per-patient-enrolled-pricing-structure-231014-4413673/ 2014-10-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/iroko-inks-new-licensing-deal-with-landsteiner-scientific-to-market-zorvolex-in-mexico-231014-4414570/ 2014-10-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/twi-biotechnologys-ac-201-secures-fda-orphan-drug-status-for-epidermolysis-bullosa-231014-4414600/ 2014-10-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-tonixs-ind-for-tnx-201-to-treat-episodic-tension-type-headache-231014-4414614/ 2014-10-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-starts-phase-iii-colorectal-cancer-trial-of-nintedanib-231014-4414621/ 2014-10-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-grants-orphan-status-for-gw-pharmaceuticals-epidiolex-to-treat-dravet-syndrome-231014-4414653/ 2014-10-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nice-recommends-gsks-skin-cancer-drug-tafinlar-231014-4414661/ 2014-10-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/oramed-releases-positive-phase-iia-trial-results-with-oral-insulin-in-type-1-diabetes-231014-4414665/ 2014-10-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/johnson-johnson-announces-major-commitment-to-expedite-ebola-vaccine-development-231014-4414669/ 2014-10-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/tapimmune-provides-update-on-polystart-vaccine-platform-applicable-to-cancer-and-infectious-disease-231014-4414671/ 2014-10-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ibio-expands-exclusive-product-collaboration-with-novici-biotech-231014-4414672/ 2014-10-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sutro-celgene-enter-multi-year-strategic-collaboration-and-option-agreement-231014-4416287/ 2014-10-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/leading-researchers-join-biogen-idec-to-advance-drug-discovery-for-neurodegenerative-diseases-231014-4416293/ 2014-10-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/certara-gets-fda-grant-to-improve-simcyps-mechderma-to-permit-drug-bioequivalence-assessment-241014-4416797/ 2014-10-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-reports-positive-results-from-two-phase-iii-trials-of-secukinumab-in-ankylosing-spondylitis-241014-4415473/ 2014-10-24T00:18:00+00:00 https://www.pharmaceutical-business-review.com/news/zymeworks-lilly-extend-deal-for-new-bi-specific-immunotherapies-on-azymetric-platform-241014-4415588/ 2014-10-24T02:49:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-to-invest-32bn-in-basel-site-development-241014-4415744/ 2014-10-24T02:50:00+00:00 https://www.pharmaceutical-business-review.com/news/medivation-licenses-anti-pd-1-immune-modulatory-monoclonal-antibody-from-curetech-241014-4416247/ 2014-10-24T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-grants-epizyme-with-notices-of-allowance-for-patent-applications-covering-prmt5-inhibitors-241014-4416253/ 2014-10-24T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/vaxart-accelerates-ebola-tablet-vaccine-development-241014-4416268/ 2014-10-24T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/islet-and-bhv-report-two-phase-iib-clinical-trials-of-remogliflozin-etabonate-to-treat-type-2-diabetes-241014-4416276/ 2014-10-24T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/nice-recommends-bayers-rivaroxaban-as-option-for-secondary-prevention-in-acs-241014-4416394/ 2014-10-24T06:48:00+00:00 https://www.pharmaceutical-business-review.com/news/relypsa-submits-nda-to-fda-for-approval-of-hyperkalemia-treatment-patiromer-fos-241014-4416438/ 2014-10-24T07:11:00+00:00 https://www.pharmaceutical-business-review.com/news/cytori-gets-fda-nod-to-resume-enrolment-in-athena-cardiovascular-trial-241014-4416487/ 2014-10-24T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-committee-recommends-astrazenecas-ovarian-cancer-drug-lynparza-241014-4416563/ 2014-10-24T07:56:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-kyoto-university-partner-on-collaborative-research-projects-271014-4416785/ 2014-10-26T23:47:00+00:00 https://www.pharmaceutical-business-review.com/news/contract-packaging-resources-recalls-assured-brand-naproxen-sodium-tablets-271014-4417300/ 2014-10-27T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/chmp-recommends-label-update-for-esbriet-in-idiopathic-pulmonary-fibrosis-271014-4417515/ 2014-10-27T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/alternaturals-plans-for-new-manufacturing-facility-to-meet-expected-revenue-growth-271014-4417527/ 2014-10-27T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/imprimis-pharmaceuticals-reports-on-positive-clinical-findings-presented-at-the-american-academy-of-ophthalmology-aao-annual-meeting-271014-4417553/ 2014-10-27T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/lundbeck-provides-update-on-new-drug-application-for-intravenous-carbamazepine-271014-4417565/ 2014-10-27T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/baxters-obizur-gets-fda-approval-to-treat-adults-with-acquired-hemophilia-a-271014-4417868/ 2014-10-27T06:10:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-committee-issues-positive-opinion-for-astellas-prostate-cancer-treatment-enzalutamide-271014-4417917/ 2014-10-27T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/mundipharmas-targin-receives-chmp-positive-opinion-to-treat-restless-legs-syndrome-271014-4418115/ 2014-10-27T08:08:00+00:00 https://www.pharmaceutical-business-review.com/news/australias-csl-agrees-to-buy-novartis-influenza-vaccine-business-for-275m-281014-4418159/ 2014-10-27T08:18:00+00:00 https://www.pharmaceutical-business-review.com/news/clinuvel-gets-ema-approval-for-scenesse-to-treat-erythropoietic-protoporphyria-271014-4418067/ 2014-10-27T08:21:00+00:00 https://www.pharmaceutical-business-review.com/news/mpi-research-buys-jasper-clinical-research-development-281014-4419831/ 2014-10-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biodelivery-to-develop-injectable-microparticle-formulation-of-buprenorphine-with-evonik-for-use-in-opioid-dependence-and-pain-281014-4420526/ 2014-10-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-breakthrough-therapy-status-for-mercks-lung-cancer-drug-keytruda-281014-4418503/ 2014-10-28T01:36:00+00:00 https://www.pharmaceutical-business-review.com/news/amunix-signs-services-and-supply-deal-with-university-of-nebraska-lincoln-to-produce-gmp-grade-xten-281014-4418893/ 2014-10-28T02:56:00+00:00 https://www.pharmaceutical-business-review.com/news/mersana-takeda-enter-commercial-license-deal-for-new-fleximer-antibody-drug-conjugate-281014-4418861/ 2014-10-28T02:59:00+00:00 https://www.pharmaceutical-business-review.com/news/octapharmas-octagam-10-now-available-for-ordering-in-us-281014-4418865/ 2014-10-28T03:12:00+00:00 https://www.pharmaceutical-business-review.com/news/roskamp-institute-discovers-new-target-for-drugs-to-treat-alzheimers-disease-281014-4418875/ 2014-10-28T03:13:00+00:00 https://www.pharmaceutical-business-review.com/news/fresenius-kabi-launches-kabiven-in-us-281014-4418871/ 2014-10-28T03:16:00+00:00 https://www.pharmaceutical-business-review.com/news/akebia-reports-positive-top-line-results-from-phase-iib-akb-6548-anaemia-trial-281014-4418884/ 2014-10-28T04:14:00+00:00 https://www.pharmaceutical-business-review.com/news/plasmatech-norgine-sign-license-deal-to-commercialize-mugard-in-australia-and-new-zealand-281014-4419443/ 2014-10-28T07:03:00+00:00 https://www.pharmaceutical-business-review.com/news/cancer-research-uk-leukaemia-lymphoma-research-partner-for-new-blood-cancer-drugs-281014-4419679/ 2014-10-28T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/drive-ab-consortium-launched-to-develop-economic-models-for-pharmaceutical-industry-281014-4419779/ 2014-10-28T07:26:00+00:00 https://www.pharmaceutical-business-review.com/news/cormedix-gets-fda-nod-to-begin-clinical-trial-for-neutrolin-281014-4419532/ 2014-10-28T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-signs-475m-option-agreement-to-acquire-f-star-and-fs102-291014-4420130/ 2014-10-29T00:04:00+00:00 https://www.pharmaceutical-business-review.com/news/us-health-coalition-issues-important-medicine-safety-tips-for-cold-and-flu-sufferers-291014-4420551/ 2014-10-29T02:38:00+00:00 https://www.pharmaceutical-business-review.com/news/gryphon-investors-takes-over-majority-stake-in-cb-fleet-291014-4420505/ 2014-10-29T02:41:00+00:00 https://www.pharmaceutical-business-review.com/news/adamas-expands-phase-iii-program-with-ads-5102-to-treat-levodopa-induced-dyskinesia-in-pd-patients-291014-4420517/ 2014-10-29T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/wcct-global-announces-involvement-in-h1n1-oral-vaccine-development-291014-4420543/ 2014-10-29T04:53:00+00:00 https://www.pharmaceutical-business-review.com/news/curis-announces-allowance-of-us-patent-covering-compounds-targeting-hdac-and-pi3k-activities-in-a-single-molecule-291014-4420535/ 2014-10-29T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/iroko-signs-licensing-deal-with-aspen-to-market-zorvolex-in-australia-and-new-zealand-291014-4421226/ 2014-10-29T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/osteros-begins-phase-i-trial-of-mbc-11-to-treat-cancer-induced-bone-disease-291014-4421250/ 2014-10-29T06:09:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-status-for-araims-ara290-to-treat-sarcoidosis-associated-sfn-291014-4421172/ 2014-10-29T06:59:00+00:00 https://www.pharmaceutical-business-review.com/news/olipass-bristol-myers-partner-for-pna-based-therapeutics-291014-4421271/ 2014-10-29T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-prometics-ind-for-plasminogen-to-treat-hypoplasminogenemia-291014-4421386/ 2014-10-29T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/triphase-celgene-extend-deal-for-iv-formulation-of-marizomib-and-bevacizumab-for-glioblastoma-291014-4421396/ 2014-10-29T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizers-pristiq-phase-iv-trial-shows-low-potential-for-sexual-dysfunction-in-adults-with-mdd-301014-4424797/ 2014-10-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/xencor-renegotiates-xmab5871-agreement-with-amgen-301014-4422270/ 2014-10-30T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/aileron-therapeutics-secures-33m-in-series-e-financing-to-advance-cancer-drug-development-301014-4422295/ 2014-10-30T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/plandai-secures-approval-in-uruguay-to-grow-cannabis-for-medical-research-301014-4422319/ 2014-10-30T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-advises-gsk-on-ebola-vaccine-development-plan-301014-4422279/ 2014-10-30T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/safc-introduces-new-protein-quality-supplement-to-increase-n-linked-glycosylation-301014-4422305/ 2014-10-30T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/protein-sciences-gets-fda-approval-for-flublok-influenza-vaccine-for-adults-aged-18-and-older-301014-4422765/ 2014-10-30T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/recro-pharma-doses-first-patient-in-phase-ii-trial-of-dex-in-to-treat-acute-pain-301014-4422831/ 2014-10-30T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/relmada-adds-15m-in-capital-to-accelerate-development-of-pain-treatment-drugs-301014-4422286/ 2014-10-30T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/mei-pharma-begins-dosing-in-me-344-phase-ib-trial-for-small-cell-lung-and-ovarian-cancers-301014-4422810/ 2014-10-30T07:14:00+00:00